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Regenerative therapies, or bone substitutes, for long bone fractures are on the verge 
of becoming standard practice. Development of a wide variety of synthetic materials has 
been undertaken in effort to improve healing of debilitating fractures. An ideal bone 
substitutes would mimic natural bone physiology. The form and function of long bones 
must first be understood in order to create the ideal regenerative material. From there, 
basic fracture healing provides key insights as to where and how fractures may advance 
to stages of non-healing. The ideal bone substitute would be both osteo-inductive and 
osteo-conductive. An effective material to promote bone healing in large defects has yet 
to be developed, and large animal preclinical models are lacking. Few large animal 
studies looking at bone regeneration exceed ninety days making long-term 
osseointegration of the bone substitute difficult. One of the most studied platforms for 
synthetic bone substitutes are nanohydroxyapatite and polyurethane composites due to 
their biocompatibility and bioresorbability. The studies detailed here focus on the 
biological assessment of a bone substitute that contains polyurethane, 
nanohydroxyapatite, and decellularized bone particles. A multitude of in vivo 
assessments were carried out to assess the impact of the bone substitute on a novel 
preclinical large animal model of long term bone healing. Baseline gait assessment 
characteristics were able to be determined for goat models relating to apparently healthy 
goats prior to the start of the bone healing model. Positive results were associated with 
long term integration of the bone substitute when the material was impregnated with the 
growth factor bone morphogenetic protein-2. The most catastrophic complication of any 
bone substitute used for long bone fractures, infection was encountered. Phenotypic and 
whole genomic characterization of the Staphylococcal associated infections, and 
subsequent osteomyelitis, were performed. It was recognized that there was an initial 
bone proliferation associated with Staphylococcus aureus associated osteomyelitis cases. 
The successful large animal preclinical model may provide an alternative to study bone 
substitutes. Conventional fixation methodologies may be removed, after sufficient 
healing time, to allow for further investigation into the integration and rehabilitation of 
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The purpose of this review is to understand the need for bone substitutes in 
clinical applications of long bone fractures. Knowledge of long bone anatomy is the basic 
first essential step towards understanding the form and function of long bones. From 
there, basic fracture healing can be understood so as to understand where and how 
fractures may advance to stages of non-healing. This gives rise to understanding when 
bone substitutes may be used and what are the most common substitutes available. 
Finally, a devastating complication of long bone fractures and the use of bone substitutes 
is infection. The use of bone substitutes, fracture healing, delayed fracture healing and 
infection are vast subjects and far from fully understood. The presented article is a 
knowledge update with more specific information given to fracture healing regarding 
growth factors, bone substitutes regarding polyurethane-nanohydroxyapatite based 



































Long bone fractures in a healthy adult are the result of major trauma, or high 
energy injury [1]. In military personnel, extremity injuries, and associated fractures, are 
the most common body region injured during combat [2, 3]. The tibia is the most 
commonly fractured long bone [2, 3]. In civilian population this it typically the result of 
falls, sporting, or motor vehicle accidents [1]. In military personnel, tibial injuries 
associated with combat are typically the result of gunshots, explosion, and improves 
explosive devices [2, 3].  
The use of regenerative therapies for human musculoskeletal defect injuries is on 
the verge of becoming standard practice. [4] Traditionally, catastrophic fractures have 
required the use of bone substitutes (grafting) when a decision has been made to salvage 
a limb [5, 6]. The gold standard for bone grafting materials has been the autograft (bone 
taken from the patient’s own body) or the allograft (cadaveric bone from a bone bank) [7, 
8]. The procedure is not without complication. Approximately 30-60% of grafting 
procedures result in one or more complications, ranging from infection to incomplete 
integration, to donor site pain [9]. In humans, the incidence of non-union fractures is 
approximately 5-10% [10]. The consensus for the definition of delayed healing or 
fracture non-union is inconsistent and subjective [11]. Musculoskeletal injuries have been 
reported to now compromise approximately 50% of all combat wounds and are becoming 
an orthopedic burden of disease highlighting the need for Food and Drug Administration 
approval of new regenerative therapies to lower the incidence of these costly fractures 
[12-14].  
This first section serves to understand typical long bone conduct as the gold 
standard for return to function after long bone fracture. The normal function, anatomy, 
and composition of long bones is reviewed first because to ensure bone substitutes 
perform suitably they must mimic the intrinsic nature of long bones. Normal fracture 
healing is then reviewed to understand gaps in which abnormal fracture healing may 
occur and the use bone substitutes are then needed. Abnormal fracture healing is 
reviewed to understand how bone substitutes have been used and when they are used in 
times that fracture healing has gone wrong. This is followed by available bone grafting 
materials both natural and synthetic. Finally, a short section is provided on the main 
complication of bone grafting, infection.  
 
Long Bone: Function, Anatomy, Composition, Cellularity 
Function 
Bone serves primarily as the body’s structural support, locomotion system, and 
adapts in response to alterations of mechanical environment [15, 16]. It provides 
maintenance for mineral homeostasis (primarily calcium and phosphorous), acid-base 
balance, and supports an environment for hematopoietic cell development and bone 
marrow production [15].   
Gross Anatomy (Organ Level) 
Regardless of mammalian species, long bones form by endochondral ossification, 
a process by which bones evolve from cartilaginous prototypes that are permeated by 
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vessels and undergo mineralization [Fig 1-1; 17, 18]1. Therefore, long bones are divided 
anatomically starting with a hollow tube, also known as the diaphysis (primary center of 
ossification), which flares at either end into the cone shaped metaphyses followed by 
growth plates and ending in rounded epiphyses (secondary center of ossification) [15, 
17]. The cylindrical diaphysis is formed by a covering of compact bone [15, 19]. The 
internal architecture of the diaphysis holds the medullary cavity [19].  Cortical bone is 
thick in the middle of the diaphysis and flares towards each metaphysis [19]. The cone 
shaped metaphysis at either end is again surrounded by compact bone, although thinner, 
while the internal structure is inhabited by cancellous (spongy) bone [19]. Both trabecular 
and cortical (compact) bone are composed of lamellae. Cortical lamellae, or Haversian 
systems, are cylindrical in shape and form a branching network [15]. Trabecular lamellae, 
or packets, are semilunar in shape and form a three- dimensional lattice of plates and rods 
with varying density [15, 19]. Metaphysis’ are responsible for transferring load into the 
bone cortex [17]. The growth plates are regions of bone elongation just beyond the 
metaphysis [17]. Finally, the epiphysis refers to the ends of long bone and have an 
internal structure similar to the metaphysis [17]. The outer layer of the epiphysis is 
thinner compact bone except where these ends articulate with adjoining bones, at which 
point they are covered in hyaline cartilage [Fig 1-2; 19, 20]. 
Long bones are covered by a double layered membrane (periosteum) except at the 
hyaline cartilage ends and where it is pierced by interesting ligaments and tendons [17, 
19]. The outer layer is fibrous, while the inner layer is cellular and retains bone- forming 
capacity beyond maturity that is reactivated during fracture healing [17, 18]. The 
medullary cavity, within the diaphysis, is filled with either predominately red 
(hematopoietic) or yellow (fat) marrow depending on the stage of life with red marrow 
being more dominate in younger age groups while yellow is more customary in older age 
groups [17]. Finally, a conceptual endosteal layer exists at the bone medullary cavity 
interface to explain functional modifications seen during adaptation events [Fig 1-2; 17].  
Blood and Nerve Supply 
The skeletal system itself receives an indulgent blood supply, estimating 5-10% of 
the overall cardiac output [19]. Arterial blood enteral through the largest nutrient artery 
via the diaphyseal cortex to divide into proximal and distal intramedullary branches 
which eventually branch into arterioles to permeate the Haversian or Volkmann’s canals 
[17, 19]. Cortical bone receives up to one-third of its blood supply to its outer surface 
from the periosteal arteries. Venous drainage is accomplished by veins that follow 
accompanying arteries [Fig 1-1; 19]. There is no lymphatic system present within bone 
[19]. Both sensory and motor nerves are found within bone [19]. Periosteal nerves are 
sensory and contain pain receptors for tearing and tension [17].  




1 All figures and tables for this chapter are presented in the appendix.  
5 
 
Microscopic Anatomy (Tissue Level) 
Long bones can be divided into four categories: woven bone, lamellar bone, 
cortical bone or trabecular bone. Woven, or immature bone, is seen in areas of rapid 
growth or states of high bone turn over [15, 19]. It is characterized by a collagen fibers 
that are laid down in a random pattern with an immense number or bone progenitor cells 
[17]. Lamellar bone is present on both cortical and trabecular bone. It is mature bone with 
systematic collagen fibers [19].  
Lamellar bone, within the cortex or just beneath the articular cartilage, is arranged 
into Harversian systems (osteons) [17]. The boundary of each Haversian system is a 
cement line [19]. The lamellae are aligned into concentric cylinders that run lengthwise 
and hold nerves and vessels [20]. Volkmann’s canals are horizontal canals connecting the 
Haversian systems to each other [21].  Between osteons, the lamellae are referred to as 
interstitial lamellae [17].  Circumferential lamellae exist when layers are oriented parallel 
to the circumference of the bone [17]. Cortical bone is almost non-porous (porosity of 5-
10%) and extremely dense [22]. Within this dense system, small holes (lacuna) exist 
within the matrix that have been made during formation, or remodeling [22]. This system 
and density give cortical bone both strength and restricted flexibility [Fig 1-3, 22, 23].  
In contrast, lamellae within the trabecular bone are arranged in parallel [17]. 
Anastomosing plates or rods orient themselves to reflect adaptation to mechanical 
stresses experienced by bone itself [17]. It is exceedingly porous (75-95%) with pores 
being interconnected and filled either marrow [22].        
Composition of Bone 
Long bones are composed of 20 to 40% organic bone matrix, 50 to 70% mineral, 
5 to 10% water, and <3% lipids. Cells involved in the structural integrity of bone are 
osteoblasts, osteocytes, and osteoclasts [15, 17].   
Organic bone matrix can be broken down into collagenous or non-collagenous 
proteins, proteoglycans, and lipids [17]. Up to 90% of the bone collagen is Type I 
collagen [22, 24]. Other collagen proteins (i.e. Types II or IX collagens) may be found in 
trace amounts as organization components or in pathologic conditions [15, 24].Type I 
collagen is a triple helical molecule composed of three amino acid chains which have 
extensive cross- linkages, both among themselves and between adjacent molecules [19, 
22]. While it has been well described, recombinant forms of type I collagen are gaining 
popularity as platforms for bone regeneration [25]. Deposition of Type I collagen 
molecules occurs in rows with perforations between adjacent molecules in the horizontal 
direction of 35 to 40 nm [17, 22]. Rows are staggered so that molecules overlap and are 
offset by a stance of 64 to 70 nm [17, 22]. Collagen molecules are connected through 
immature enzymatic cross-linkages [22]. This packaging and enzymatic cross-linking 
provides the strength and insolubility to bone [17]. The collagen fibers arranged in 
parallel make up lamellae and are arranged either concentrically or parallel depending on 
if they are in cortical or trabecular bone [17].  
Non-collagenous proteins are numerous with a wide range of functions from 
cytokines to enzymes to adhesion molecules [17, 19]. Important non-collagenous proteins 
and their proposed roles are summarized in Table 1-1 [26, 27]. Proteoglycans and lipids 
are the final important components of bone. While the role of proteoglycans remains 
unclear, it is thought to potentially attract water. [17, 19]. This allows resistance to 
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compression due it’s composition of hyaluronic acid, chondroitin and dermatan sulfates, 
heparin sulfate and heparin, and keratin suflate aggregated to a protein core [17, 19]. 
While lipids in bone may aid in promoting calcification by binding calcium to cell 
membranes [17]. Water may be freely mobile, bound to the surface in the mineral phase, 
or bound as a hydroxyl component of other molecules in bone [22]. An inverse 
relationship exists between the water content of bone and its mechanical properties with a 
lower water content significantly increasing bone stiffness while a higher water content 
reduces it [22]. Bound water is associated with bone strength and mobile water is 
correlated with the modulus of elasticity and the porosity of bone [22].  
Bone mineral exists in a crystal form composed mainly of hydroxyapatite [19, 
22]. The mineral crystal orientation giving bone anisotropic properties while providing 
significant hardness, stiffness and strength [17, 19]. The main minerals contributing to 
the hydroxyapatite crystal are calcium and phosphorous [22]. Other major minerals 
including calcium and phosphorous are carbonate, magnesium, sodium, manganese, zinc, 
copper and fluoride to make up 65% of bone by weight [17]. Osteoid, or unmineralized 
organic matrix, is originally laid down in woven bone and must undergo mineralization to 
become lamellar bone [17, 19, 22]. The process of mineralization may differ based on if 
bone is going from unwoven to lamellar bone (maturation) or if bone is going from 
lamellar bone to lamellar bone (remodeling) [17, 19]. With remodeling, mineralization 
may occur at nucleation sites within the collagen itself because specific proteins such as 
osteonectin or bone sialoprotein may act as a nidus or the mineralization process to occur 
[17, 19].   
Alternatively, when bone undergoes maturation mineralization it is thought to 
occur through extracellular matrix vesicles in an orderly process [17, 19, 22]. An 
overview is one in which osteoid is produced, matures, and mineral is exchanged for 
water in the hole zones of collagen molecules to not disrupt spatial organization [17, 19]. 
The exact mechanism by which mineral comes to be concentrated within extracellular 
matrix vesicles is poorly understood with physiologic fluids perhaps becoming 
supersaturated with mineral, crystal inhibitors present, genetic control, hormonal control 
and Vitamin D all playing roles [17,19]. Once vesicles (cytoplasmic blebs) are formed 
from bone cells in woven bone and minerals are concentrated, they precipitate in the form 
of amorphous crystals with the vesicles thought to contain specific enzymes and 
phospholipids to bone mineralization [17]. After precipitation, a specified mass is 
reached and the amorphous crystals becomes crystalline hydroxyapatite and are deposited 
within the hole zones of collagen molecules [17, 19] Surfaces of collagen fibers must be 
mineralized as well and in order for the process of mineralization to continue, inhibitors 
of mineralization must be destroyed [17]. After this occurs, woven bone is no longer 
present and the new lamellar bone can undergo further remodeling to finish becoming 
mature bone.  
Bone cells that affect structural integrity of bone are osteoblasts, osteocytes and 
osteoclasts [17]. Osteoprogenitor cells exist as undifferentiated mesenchymal cells that 
have the properties of stem cells in that they have the ability to differentiate in order to 
give rise to and maintain new bone cells (osteoblasts) which synthesize new bone matrix 
(osteoid) on bone surfaces [15, 17, 19]. They arise from self- renewing pluripotent stem 
cells in various tissues and commitment to the osteoblast lineage requires the canonical 
Runx2/Wnt/B-catenin pathway and associated proteins [15, 28]. In bone, these 
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committed yet undifferentiated mesenchymal stem cells are present on the endosteum, 
Haversian and Volkamann’s canals, as well as the inner layer of the periosteum as bone- 
lining cells [19]. 
Osteoblasts arise from osteoprogenitor cells and their shape is dependent on their 
amount of activity [15, 17 19].  Inactive, or quiescent, osteoblasts resemble discs and are 
thought to form the endosteum [15, 17]. Active osteoblasts are plump with extensive 
organelles as they are responsible for bone matrix (osteoid) synthesis and secretion, 
mainly Type I collagen and glycosoaminoglycans [15, 17, 19].  Interaction occurs 
between osteoblasts and mature bone cells (osteocytes) in the regulation of calcium 
homeostasis and mineralization of bone [17, 19, 29]. Osteoblasts respond with osteocytes 
to mechanical stress to mediate changes in bone shape and size [15, 17, 19]. Osteoblasts 
then differentiate into primary bone cells (osteocytes) depending on a variety of growth 
factors and transcription factors. For our purposes, it is assumed that molecular and 
cellular signaling proceeds in a normal fashion. Fig.1-4 provides a brief overview for 
commitment of a multipotent mesenchymal stem cell to a mature osteocyte with growth 
factors and signaling outlined in Table 1-1 [30].  For simplicity, osteoblasts secrete 
osteoid or new mineralized bone, a key marker when evaluating bone formation.  
Osteocytes lie within lacunae within mineralized bone and represent terminally 
differentiated osteoblasts [15]. They function within syncytial networks to support bone 
structure and metabolism [15]. They make contact with other osteocytes or osteoblasts by 
the use of long cytoplasmic processes (filopodia) that lie within the canaliculi in 
mineralized bone [15, 17]. Osteocytes themselves retain limited capacity to form new 
bone, and only under extreme stress seem to play a limited role in bone resorption [15, 
17, 31]. 
Osteoclasts arise from hematopoietic stem cells of the granulocyte-monocyte 
origin [15, 17]. They are multinucleated, and are the only cells known to be capable of 
resorbing bone. Osteoclasts are able to bind to bone matrix via integrin receptors present 
in the osteoclast membrane [15]. Once bound, they are able to resorb bone. Briefly, the 
mineral present in bone is dissolved by secretion of hydrogen ions [17]. Next, the 
collagen present in bone matrix is cleaved into polypeptide fragments [17. This action 
creates a concavity in the bone called Howships lacuna [17].  
Bone remodeling occurs in four sequential phases; activation, resorption, reversal, 
and formation [15]. It is the process by which bone maintains strength and mineral 
homeostasis [15]. It occurs by three mechanisms; apposition and resorption at the 
endosteal surface, apposition and resorption at the periosteal surface, and activation, 
resorption and formation at the Haversian system [19]. Remodeling is first activated by 
an interaction between osteoclasts and osteoblasts through a “coupling” mechanism that 
is poorly understood [19]. Resorption is carried out by osteoclasts in the form of a 
“cutting cone” [19]. The defect then becomes filled with fibrovascular tissue [19]. The 
outer edge of where resorption ends and bone formation begins is known as the “cement” 
or “reversal” line [19]. Finally, bone formation is carried out by osteoblasts. This 
remodeling process may provide the key insights into specific cytokines or cell signaling 
that allow the process of fracture repair to be more closely understood. Attention will be 
paid to bone morphogenetic protein-2 later on as it is a prominent cytokine upregulated 




In this section, the normal fracture repair sequence is reviewed as the gold 
standard for a bone healing. Fractures are the most common traumatic injuries and 
approximately 10% of them do not heal properly in humans [33]. Fractures themselves 
are the result of structural failure of bone [34]. They are the result of loading factors on 
bone itself and the intrinsic nature of bone [34]. The magnitude, rate and direction of load 
influence the likelihood of fracture because bone is viscoelastic, constantly under strain, 
and allows stress reduction to occur in a time-dependent manner [34]. Cortical bone has 
different mechanical properties dependent on the direction it is loaded in (anisotropy) 
[34].  Bone is strong but brittle due to its composition as described above and various in 
amounts of cancellous versus cortical bone dependent on the area of bone allowing bone 
to fracture differently dependent on the area that force is directed [34].  
Fracture healing is regulated by the nature of the fracture itself, the stability of its 
fixation, and biological processes [33]. One of the most widely examined treatments for 
enhancing fracture healing is bone morphogenetic proteins [33]. In order to enhance the 
use of bone morphogenetic proteins, conditions for fracture healing must be optimized 
[33]. The sequential four-stage model is reviewed to describe the fundamental events that 
occur over a timeline of fracture healing [35]. There are often significant overlaps 
between the stages [35].  This will provide the ideal timeline for which bone substitutes, 
often loaded with bone morphogenetic proteins, should aim to mimic natural bone in 
terms of repair followed by integration or degradation of the substitute itself.  
Fractures may heal as a result of direct (primary) or indirect healing (secondary) 
[36]. Direct fracture healing is the result of correct anatomical reduction of the fracture 
ends, without any gap formation, and a stable fixation [36]. In the tibia, and other 
associated long bones, the most common form of fractures healing is indirect [36]. 
Indirect healing involves both endochondral and intramembranous bone healing, but does 
not require perfect anatomical reduction or rigid stable conditions [36]. A four-stage 
model to describe the basic events that occur during indirect fracture healing has been 
developed from histological observations of healing fractures [35]. The stages consist of 
inflammation, soft callus formation, hard callus formation, and remodeling [35]. An 
accelerated overview is provided by Fig 1-5 with a mouse model of fracture healing that 
occurs in 1 month [33].  
Stage I- Inflammation 
Immediately following a fracture, an acute inflammatory response begins and 
peaks within the first 24 hours [36]. Inflammation typically subsides by 7 days [36]. 
Initially there is disruption to soft tissue integrity, disruption to normal vascular function, 
and a hematoma is generated [35, 36]. The hematoma coagulates in, and around, the 
fracture ends and within the medulla to form the initial template for a fracture callus [36].  
There is a secretion of numerous proinflammatory cytokines. The main inflammatory 
cytokines have previously been described in Table 1. Mesenchymal stem cells associated 
with bone formation and repair originate from the periosteum, bone marrow, circulation, 
and surrounding soft tissues play an initial role in this early stage of fracture healing [35, 
36]. Finally, once the initial clot has formed, reorganization into granular tissue begins 
with phagocytic cells clearing degenerated cells and debris [35]. 
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Stage II- Soft callus formation 
Soft callus formation begins concurrently with the end stage of the immediate 
inflammatory phase [35].  It provides the cartilaginous template for hard callus formation. 
It forms as a result of the endochondral ossification process for bone healing [35]. Cells 
responsible for forming this semi-rigid, principally avascular, soft callus are chondrocytes 
and fibroblasts [35]. Cartilaginous regions grow and merge, forming a central 
fibrocartilaginous plug that splints the fracture [35]. Chondrocytes then undergo 
hypertrophy and mineralization before undergoing apoptosis. Exact growth factors that 
stimulate fibroblast and chondrocyte proliferation are numerous. For an up to date list, 
the reader is referred to a current article by Schindeler et al [35]. In response to the 
various factors, chondrocytes generate large amounts of extracellular matrix protein, 
mainly types II or X [35]. Vascularization of the soft callus is stimulated by numerous 
pro-angiogenic growth factors some of which are briefly mentioned in Table 1-1. 
Stage III- Hard callus formation 
This stage of bone repair is characterized by high levels of osteoblast activity. 
Vasculature plays a critical role in terms of increased oxygen tension being necessary for 
osteoblast differentiation. The formation of mineralized bone matrix occurs and arises 
directly from the peripheral callus in areas of stability [35]. Revascularization occurs 
along with removal of the soft callus [35]. This new initial woven bone is irregular, 
containing both proteinaceous and mineralized extraceullar matrix [35]. Mechanical 
stability, and the replacement of calcified cartilage by woven bone marks the end of hard 
callus formation with bone remodeling beginning to take place concurrently [36]. 
Stage IV- Bone remodeling 
The initial step in bone remodeling involves converting irregular woven bone into 
lamellar bone and restoring the original cortical structure [35]. Osteoclasts become the 
key cell type as they become polarized to adhere to, and resorb, mineralized bone in areas 
that are irregular [35]. These irregular areas are known as “Howship’s lacuna” [35]. Once 
resorption is complete, osteoblasts lay down new bone on the irregular surface [35]. 
Molecular signaling is again complex and beyond this limited discussion. 
Bone Morphogenetic Protein-2 
Clearly there are numerous cytokines and growth factors responsible for initiation 
of fracture repair. The aim of this review is to highlight the bone morphogenetic proteins 
as they are known for osteoinductive capacity during fracture repair [37]. Bone 
morphogenetic proteins are members of the transforming growth factor beta superfamily 
with activity that was first identified in the 1960s [38, 37]. They are the most extensively 
reviewed candidates for fracture repair and are available in synthetic forms either derived 
from Chinese hamster ovary cells or E. coli [33, 37). Although there are numerous bone 
morphogenetic proteins, the most studied and FDA tested are BMP-2 and BMP-7 [33]. 
BMP-2 itself is an endogenous mediator of fracture repair [39]. It is necessary for 
fracture repair and in mice lacking BMP-2 spontaneous fractures do not resolve with time 
[39].  Unfortunately, Large amounts of BMP-2 are difficult to produce and extremely 
costly [40]. There is increasing evidence of deleterious side effects of associated with off-
label use of BMP-2 products despite its ability to elicit an outstanding pro-osteogenic 
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effect [41]. This may associated with the large initial release of the protein from various 
BMP-2 containing products [42, 43].  While the majority of recombinant human BMP-2 
(rhBMP-2) is traditionally derived from Chinese hamster ovary cells, E. coli derived 
rhBMP-2 has been shown to show compatible fusion rates [40, 44-46]. E. coli derived 
rhBMP-2 is more cost effective and has shown potential as a growth factor capable of 
elution from scaffolds with a pore size of 100-300 um [44]. In typical fractures, BMP-2 is 
upregulated for up to 4 weeks supporting the idea that an alternative strategy is to have a 
sustained release of BMP-2 allowing for enhanced osteogenic differentiation while 
potentially mitigating side effects [32, 42, 47, 48].  Currently recombinant human BMP-2 
and -7 are available under various regulatory conditions; however, testing is still under 
way as it is still unknown how to use these potent proteins safely and effectively [33]. 
Newer studies have explored other various BMPs and their effects on fracture repair with 
particular attention to BMP-4 and 6 with promising results [50, 51].  
These stages of fracture repair are not separate from one and another [35]. For 
example, cartilage mineralization, vascular invasion and woven bone formation occur 
concurrently with the replacement of the peripheral callus with lamellar bone [35]. It is 
important to remember that fracture repair is highly regulated and influenced by 
numerous factors such as cellular, molecular and genetic factors [35]. Further information 
regarding overlap of molecular signaling, interactions and phases is beyond the scope of 
this review and the reader is referred to other articles [35, 36].  
 
Abnormal Fracture Healing (Delayed and Non-unions) 
When a fracture is unable to heal or heals in a manner slower than expected it 
may be classified as a non-union or delayed union [52]. In human patients, the average 
risk of nonunion per fracture is near 2% with up to a 10% incidence in elderly patients or 
clavicular and tibial fractures [53]. The incidence of non-union is highly dependent on 
injury, host factors, and is site dependent [54]. Consensus for the definitions of delayed 
and non-unions currently do not exist, are inconsistent and subjective [55]. In 2007, 
Giannoudis et al came up with the diamond concept [56]. This concept required 4 key 
elements that every fracture must have to heal. They are the presence of osteogenic cells, 
growth factors, mechanical stability with the requirement of tissue vascularity, and a 
stable osteoconductive scaffold [55, 56].  
With a delayed union, the fracture goes through the normal stages of healing 
clinically, but the radiographic appearance of fracture healing is delayed [52]. One 
definition may be “a fracture in which healing has not occurred in the expected time and 
the outcome remains uncertain” [55]. Factors that may induce a delayed fracture include 
a reduced blood supply, or infection at the fracture site [52]. These factors may be more 
prevalent in fractures where the skin surface has been disrupted and the bone is exposed 
to the environment (open) versus a fracture where the skin is intact (closed) [52]. 
Additionally, if the repair of the fracture has been too rigid, callus formation will be 
inhibited and a gap of greater than 1 mm will delay union in human patients [52].  
A non-union occurs if the fracture has failed to progress to the stage of a bridging 
callus by 6 months [52]. However, the United States Food and Drug Administration 
defines non-union as a fracture that must be at least 9 months old and has not shown 
signs of progressive healing for 3 consecutive months [55]. Alternative definitions 
include a timeline of 6-8 months, or twice the time in which a fracture should heal [55].  
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Some authors feel that specifying a time for every fracture is not helpful [55]. One 
definition for a non-union, as described by one author, could be a symptomatic fracture 
with no potential to heal without intervention [55]. In humans, general factors on the 
patient side include age, corticosteroid therapy, and systemic disease, but these are 
uncommon in animals [54].  
Non-unions may be classified into two broad categories based on the Weber and 
Czech classification system [55]. They may be either hypertrophic or atrophic 
(Harwood). With hypertrophic non-unions, the fracture site is typically hyper-vascular 
with potential for biological activity [55]. This is a fracture that typically can be resolved 
with improved mechanics [55]. Under atrophic conditions, the opposite is true, and the 
site is hypo-vascular and incapable of biological activity. These fractures require 
additional therapies as changing the mechanical environment alone will not solve the 
fractures inability to heal [55].  
The first requirement for fracture healing is the presence of osteogenic cells [56]. 
Lack of these cells may arise from fractures that are open to the environment or those that 
have undergone extensive surgical exposures [55]. Additionally, systemic biology of the 
patient may affect the availability of osteogenic cells [55]. Finally, infection is 
detrimental to these cells leading both to injury and reduced ability of local tissue to 
support cellular healing [55].  
The second key element leading to non-union is a lack of signaling molecules, or 
growth factors. These molecules may be more important in the initial stages of fracture 
healing as they are very active at the fracture hematoma site [55]. These growth factors 
are secreted from numerous cells as reviewed in Table 1-1. With open fractures or 
procedures that lead to a disturbance in the healing process during any time of fracture 
healing, the environment for callus formation becomes disrupted, predisposing healing 
towards a non-unions [55]. These signaling molecules are most detrimentally affected by 
a loss of vascularity and perfusion [55].  
Fracture site stability is the third key element that will profoundly alter the ability 
of a fracture to heal. This may be the result of fracture treatments that result in either 
excessive motion (i.e. a conservative fracture managed in a conservatively) or excessive 
stability (i.e. a fracture that has not been adequately reduced allowing for too large a 
fracture gap to persist, and there is a loss of normal mechanical stimulus) [55]. Fractures 
that have excessive motion are more likely to result in hypertrophic non-unions. Atrophic 
non-unions are more likely to be associated with excessive stability due to the loss of 
mechanical stimulus that results in secondary bone healing if a fracture gap is too large 
for primary bone healing [55]. According to Perren’s strain theory, fractures with 
excessive motion do not progress beyond the early stages of soft tissue healing while 
those with excessive stability do not progress through the stages of secondary bone 
healing [55]. Further information regarding the types of fracture repair and various 
stabilizing methodologies are biomechanical in nature and beyond the scope of this 
review.  
The second part of the third key element is fracture site vascularity. If vascularity 
is decreased then there will be fewer cells available for repair, signaling and production 
of substrates [55].  This may lead to potential bone necrosis further reduction in the 
potential for healing and enhancing the local environment for infection [55]. Vascularity 
may be disrupted due to high energy fractures, open injuries, or when there is stripping 
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and disruption of the local soft tissue supply and periosteum [55].  Finally, open surgical 
fixation may further disrupt blood supply necessitating the need for respect to fracture 
biology and evaluation of any potential enhancements that would preserve vascularity 
[55].  
Finally, the osteoconductive scaffold is the final part of fracture healing. If bony 
apposition is achieved the necrotic bone present within the fracture will act as the 
osteoconductive scaffold for osteogenic cells [55]. This element of fracture healing deals 
with the micro-architecture of the fracture environment as it relates to cellular migration 
and adhesion [55]. In order to stimulate new bone to bridge a gap, osteogenic cells must 
be able to communicate across some type of scaffolding environment that is conducive to 
cellular communication that promotes bone growth [55].  
Treatment of a delayed or non-union fracture should be focused around restoring 
the 4 key elements of fracture healing. While mechanical stability and tissue vascularity, 
and osteogenic cells are beyond the scope of this review, we aim to evaluate potential 
alternatives for osteoconductive scaffolds and growth factors that may be used when this 
element of fracture healing is in jeopardy and cannot be fixed by means of traditional 
therapies that are reviewed next.  
 
Osteoconductive Scaffolds 
Osteoconductive scaffolds may take many forms as the sole goal of the scaffold is 
to provide osteogenic cells the ability to communicate with each other to promote bone 
growth. The scaffold may be a bone graft material, a ceramic material, a synthetic 
material, or a combination of the above.  Ideally the combination should promote a bone 
healing response by providing osteogenic, osteoconductive, or osteoinductive activity to a 
local site [57]. Osteogenic may be defined as a material that contains living cells capable 
of differentiation into bone, while an osteoinductive material provides a biologic stimulus 
that induces local or transplanted cells to enter a pathway of differentiation leading to 
mature osteoblasts [57]. Looking more closely at osteoconductive materials, these 
promote bone apposition to its surface, functioning in part as a receptive scaffold to 
facilitate enhanced bone formation [57].  
The typical gold standard for bone grafting has traditionally been autografting [7, 
57]. This has been followed by allografting and then xenografting. Autografting possess 
all the properties required for grafting while retaining complete histocompatibility as it is 
a graft taken from the patient (or donor) themselves [7]. It is osteoinductivece, 
osteoconductive, and osteogenic [7]. The supply of autogenous graft material however is 
self-limiting and does not come without cost [7]. Donor site morbidity can lead to major 
or minor complications and have been reported at rates of up to almost 21% [7]. 
Allografting is taking a piece of bone from a cadaver or donor rather than from the 
patient themselves. It is available in either cancellous, cortical, or demineralized bone 
matrix forms [7]. It is typically osteoconductive, while demineralized bone matrix may 
processed in a way to retain osteoinductive properties [7]. If the graft is cortical, then it 
may retain some structural support properties in addition to being osteoconductive [7]. 
Allografts are at a disadvantage in that they do not retain osteogenic properties; however, 
they are available large quantities and not associated with donor site morbidity or 
increased surgical operative time [7]. The large disadvantage of allografts is the potential 
for transmission of viruses and other infective agents and the potential for an immune 
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response from the recipient necessitating a match with the donor [7]. Xenografts are are 
based on natural hydroxyapatite and deorganified bone that is obtained from a species 
other than the host species [58]. They are strictly osteoconductive [58]. The concern is 
again for a risk of a host-immune response [58].  
Beyond more traditional grafts are the use of substitute materials. Some of the 
first bone graft materials used are known as bioceramics [7, 58]. Bioceramics are neither 
osteoinductive nor osteogenic [7]. They work by creating a scaffold to promote 
osteosynthesis [58]. Bioceramics vary in terms of rate of re-absorption and mechanical 
properties depending on which ceramic is used [7]. These rates vary widely from as fast 
as four weeks to as long as 18 months [7]. Based on this, researchers have been 
attempting to optimize the characteristics of bioceramics by creating composites of 
various bone graft substitues [7]. There are four main types of bioceramics, calcium 
sulphate, calcium phosphate, triacalcium phosphate, and coralline hydroxyapatite [7]. 
They come in multiple forms and combinations each seeking to provide the optimal 
osteoconduction, osteoinduction, and osteointegration that most closely resembles the 
autografts [58].   
A second class of substitute materials are the polymer-based substitutes. While 
natural polymers exist, they are rarely used alone [59]. Natural polymers include 
collagen, alginate, agarose, chitosan, fibrin, and hylaronan [59]. The benefit of synthetic 
polymers is that they can range from nondegradadable to fully biodegradable and offer 
more flexibility and processability into different shapes and sizes [59]. Similar to 
bioceramics, they can be found in different forms and manufactured in a variety of ways 
[59]. While ceramic materials resemble components of bone, they are brittle, do not 
match mechanical properties of bone and are unsuitable for growth of soft tissues that 
enhance different cellular receptors [60].  The most common synthetic polymers are 
aliphatic polyesters such as polycaprolactone, polactic acid and its copolymers such as 
polylactide-co-glycolide, and polyglycolic acid [60]. Additional commonly used 
polymers for bone tissue engineering include poly(vinyl alcohol), poly(propylene 
fumarate) and polyurethane [61]. Functional groups or side chains can be incorporated 
into synthetic polymers thus allowing them to be bioactivated in regards to bone tissue 
[60].  
Due to polymers tending to be too flexible and ceramics tending to be too brittle, 
recently, composite materials have been made of polymers reinforced with ceramic fillers 
[60]. The goal is to create a reinforced porous scaffold with enhanced bioactivity and 
controlled resorption rate [60]. One of the most researched polymer composites is a 
nanohydroxyapatite/polyurethane composite (nHA/PU) [62, 63].  While there has been 
extensive research into the exact ratio of nHA to PU it has been shown to have excellent 
cytocompatibility regardless of hydrothermal preparation methods [63-66]. Additionally, 
it has been shown to have the capability of eluting rhBMP-2 in a rat model [67]. It has 
shown promising degradation and integration capabilities into long bones in small animal 
models [68]. Alternatively, this combination is suitable to the addition of other 
regenerative materials such as bioactive glass [69]. Currently, there is a lack of large 
animal studies, and commercialization methods that prevent this promising composite 





 One of the most devastating and common reasons for either non-union or failure 
of an osteoconductive scaffold is infection. Bone infection is termed osteomyelitis [70]. 
Osteomyelitis is an inflammatory bone disease caused by an infecting microorganism 
[70]. The end result is progressive bone loss and destruction accounting for significant 
morbidity and expense [70-73]. Opportunistic Gram-positive staphylococci, specifically 
Staphylococcus aureus (SA) are responsible for up to 75% of clinical osteomyelitis cases 
[72].   
Staphylococcus aureus (SA) is a gram positive bacteria that is both a commensal 
and a pathogen[75]. It is the most common pathogen in osteomyelitis (OM) [72, 74]. OM 
is most commonly classified using the Waldvogel classification system [75]. One branch 
of this system is contiguous-focus OM (infection from trauma or surgery with direct 
implantation of organisms) which provides key insights into the how SA is able to infect 
bone as healthy bone is resistant to infection [76]. SA has evolved to overcome this 
resistance and infect bone in three key ways. The first is through genes that encode 
microbial surface component recognizing adhesive matrix molecules (MSCAMMs) that 
allow it to attach to bone cells (osteoblasts) [77]. The second is through biofilm formation 
that provide a safe haven from both the immune system and antimicrobials [72]. Finally, 
the last is the ability of SA to invade osteoblasts themselves, and survive in an altered 
metabolic state [78, 79].  
Currently, very little is known about how the SA-osteoblast relationship results in 
bone formation. It may be that infected osteoblasts release inflammatory cytokines within 
the first few days of infection, similar to osteoblasts after the first few days of an injury 
[80]. Thus, infected osteoblasts may play a role in the initial inflammatory phases of bone 
production prior to shifting activity to osteoclastic bone resorption and overall bone loss 
[72]. Additionally, it may be that the exact strain of infectious SA plays an important 
role. It has been shown that SA strains lacking genes that encode certain MSCRAMMs 
are less likely to cause OM infections in animal models [81, 82]. A key development in 
attempting to elucidate the SA-osteoblast relationship has been ability to determine 
difference in strains of bacteria, and the presence of these genes, has been the use of 
multilocus sequencing [83, 83]. One relatively novel sequence type (ST) of SA is ST 398, 
which we have shown it to be putatively capable of producing a large amount of bone 
formation. Additionally, this sequence type has a proven track record of being a one-
health problem, representing a newer sequence type from previous studies investigating 
any potential SA-osteoblast relationships that result in bone formation [85-88].  
Investigation of the sequence specific SA-osteoblast relationship may start with 
physiologic evidence of bone formation. Evidence of such formation may be the result of 
osteoblast inflammation which has been well studied with in both in-vitro and in-vivo 
models of SA infection [89-94]. Osteoblast inflammation in-vitro may be characterized as 
osteoblast invasion by SA and resultant cell death (apoptosis), a release of inflammatory 
markers (cytokines), and a production of bone formation markers (type I collagen, 
osteopontin, osteocalcin) [89-93]. This inflammation may be ST dependent with ST 398 
capable of producing more periosteal new bone as compared to known laboratory strains. 
These in-vitro studies would then be definitively confirmed in a known animal model of 
infection providing the necessary link for definitive phenotypic evidence that the amount 
of bone formation is sequence dependent [95]. Genetic comparisons of sequence types 
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may additionally elucidate how this little studied ST 398 is capable of physiologically 
altering the SA-osteoblast relationship towards bone formation.  
Next, altering the ability of SA to attach to osteoblasts may provide the necessary 
evidence to elucidate the mechanism of the SA-osteoblast relationship in the production 
of bone formation. The MSCRAMMs are protein surface adhesins that provide the ability 
to attach to osteoblasts [96]. The synthesis of these surface adhesins is activated by global 
regulatory loci such as sarA and cna, while environmental signals are generated to 
activate agr [97]. sarA has been implicated in SA’s ability to form biofilms, while agr 
has been implicated in SA’s virulence through production of hemolysins [97]. This leaves 
cna which produces collagen binding protein (Cna) to become attached to osteoblasts, 
and internalized to potentially alter osteoblast activity [97]. It becomes particularly 
important in terms of direct inoculation (trauma or surgery) as osteoblasts are being 
primed for bone repair and set to produce type I collagen [73]. Therefore how SA OM 
results in new bone formation may be tied to the function of cna during direct 
inoculation. This has been a remotely investigated phenomenon in terms of bone 
formation. At present SA OM has been primarily identified as bone losing disease [70, 
72]. Therefore, current treatment and prevention efforts do not consider the potential 
overall impact of bone formation as a therapeutic advantage in areas devoid of bone 
formation or as a potential target for treatment to limit its formation (reduce virulence) in 
areas where it has become excessive.   
 
Conclusion 
In summary, a bone substitute should be osteconductive thereby mitigating the 
loss of cell signaling that occurs with non-unions and returning fractures to proper 
fracture healing and restoring bone back to its proper anatomical and functional form. If 
they are capable of either eluting an antimicrobial or altering osteoblast activity towards 
resisting infection, they are of added benefit as this is the primary and most devastating 
complication. BMP-2 remains the most investigated growth factor with the most potential 
towards accelerating fracture healing that may be eluted from osteoconductive scaffolds. 
Investigation is still necessary for finding the most effective dose and delivery of this 
potent growth factor. Nanohydroxyapetite and polyurethane composites are some of the 
most studied bone regenerative scaffold composites which need FDA approval for 
commercial manufacturing and large animal testing prior to becoming clinically usable 
bone substitutes. The end goal for any bone substitute should always be to return long 
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Figure 1-1. Endochondral ossification and long bone blood supply.  
Image curtesy of Gasser J.A., Kneissel M. (2017) Bone Physiology and Biology. In: 
Smith S., Varela A., Samadfam R. (eds) Bone Toxicology. Molecular and Integrative 








Figure 1-2. Anatomy of a long bone.  
Image curtesy of Jee, W., & Weiss, L. (1983). Histology: Cell and tissue biology. 







Figure 1-3. Haversian systems.  
Image courtesy of Elgazzar, A. H. (2017). Basic Sciences of Bone and Joint Diseases. In 






Table 1-1. Major cytokines, growth factors, non-collagenous proteins and their 
proposed roles. 
Type Proposed Function Origin  
Cytokines 
Tumor necrosis factor- 
alpha  
(TNF- IX) 
Stimulates bone resorption, 
directly inhibits osteoblastic 
collagen synthesis,  
Osteoblasts  
Interluekin-1(IL-1) Increases bone resorption Osteoblasts, Mononuclear 
cells 




Local regulator of skeletal 
metabolism 
Osteoblasts 
Stored in the extracellular 
matrix 
Transforming Growth 
Factor Beta (TGF-B) 
Enhance cells replication, 
collagen synthesis, and 
matrix formation 
Initially platelets  
Multiple tissues including 
bone 
Insulin like Growth 
Factor-1 (IGF-1) 
Stimulate preostoblastic cell 
replication 
Liver or skeletal tissue  
Platelet-Derived Growth 
Factor (PDGF) 
Increases bone collagen and 
matrix, stimulates bone 
resorption collagen 
degradation 
Originally platelets, but 
suspect osteoblasts  
Adhesion proteins 
Osteopontin  Bone resorption, regulate 
mineralization- potent 
inhibitor 
Osteoblasts and osteoclasts 
Fibronectin Binds to integrin receptors 
located at cell surface 
Regulates mineralization by 




Osteocalcin  Metabolic regulation  Osteoblasts and osteocytes 
Calcium Binding Proteins 
Osteonectin  “bone connector”, strong 
affinity for collagen and 
mineral, bind calcium 
Secreted by osteoblasts  
Bone Sialoprotein 
 





Figure 1-4. Commitment of a mesenchymal stem cell to an osteocyte with important 
proteins.  
Commitment starts with the Runx2/Wnt/B-catenin pathway. The major protein in bone is 
collagen I (col I) with other non-collagenous proteins outlined in Table 1. Image 
modified and courtesy of McCawley, L. J., & Matrisian, L. M. (2001). Matrix 


























Figure 1-5. An accelerated overview of the four stages of bone healing 
(inflammation, soft callus formation, hard callus formation, remodeling) as seen in a 
mouse model of long bone fracture healing.  
Image courtesy of Einhorn, T. A., & Gerstenfeld, L. C. (2015). Fracture healing: 

















CHAPTER 2.  
USE OF A PRESSURE-SENSING WALKWAY SYSTEM FOR BIOMETRIC 




 A version of this chapter was originally published by Rebecca E. Rifkin: 
 
 Rifkin, R. E., Grzeskowiak, R. M., Mulon, P. Y., Adair, H. S., Biris, A. S., Dhar, 
M., & Anderson, D. E. (2019). Use of a pressure-sensing walkway system for biometric 
assessment of gait characteristics in goats. PloS one, 14(10).  
  
 This article was published by PlosOne publications in the journal PlosOne in 
2019. It has been reprinted with permission from Rifkin, R.E., Grzeskowiak, R.M., 
Mulon, P.Y., Adair, H.S., Biris, A.S., Dhar, M., & Anderson. D.E. Use of a pressure-
sensing walkway system for biometric assessment of gait characteristics in goats. Plos 
one, 14 (10): doi:10.1371/journal.pone.0223771. Copyright 2019 PlosOne. Biometric gait 
assessment, statistical analysis, and all study design was performed at the University of 
Tennessee in Knoxville. As such this chapter will address all conclusions drawn from the 
data.   
 
Abstract 
The purpose of this study was to quantitatively assess gait characteristics and 
weight-bearing forces during ambulation in goats free of lameness using a pressure-
sensing walkway as a biometric tool for stride, gait, and force analysis. Forty-six non-
lame adult goats ranging in age from 5 to 6 years, mixed-breeds, and with a mean body 
weight of 52 ± 7.1 kgs were used. Goats were trained to walk over a pressure-sensing 
walkway. Data for analysis was collected on 2 different days, 3 days apart. On each day, 
2 to 5 walking passes, in the same direction, were captured for each goat. Data from 2 
valid passes meeting the criteria for consistent walking gait on each day were averaged 
then used for analysis. Analysis was performed, including the day-effect, for stride, gait, 
and force characteristics. Of the 46 goats enrolled in the study, complete data sets were 
achieved in 33 (72%) goats. Gait biometrics were similar among the assessment days; 
therefore, all data was pooled for the purpose of characterizing data for individual limb 
and biometric parameter comparisons at the individual goat level. Statistical analysis 
revealed that no difference within the paired limbs, and that there were significant 
differences between the front limbs and hind limbs. Maximum force and maximum peak 
pressure were significantly greater for the front limbs as compared with the hind limbs (p 
< 0.001). Based on the results, gait and force characteristics can be consistently measured 
in goats using a pressure-sensing walkway during a consistent walking gait. Goats apply 
greater force to the forelimbs during the weight-bearing phase of stride as compared with 
the hind limbs. The use of objective assessment tools is expected to improve the ability of 
researchers and clinicians to monitor changes in weight bearing and gait and will 











Goats are often chosen as a model for orthopedic research [1-4]. Advantages in 
the use of goats in research include ease of handling, ease of training, size, weight, and 
ambulatory characteristics relevant to translational research in humans [3, 4]. More 
detailed information concerning gait in goats is needed, especially when translation of 
data to implants and materials for use in people are needed, as goats have suitable 
metabolic and bone remodeling rates for translation to people [4]. Currently, subjective 
visual assessment of gait (Visual Lameness Score; VLS) is the standard of care in 
practice to assess lameness [5-12]. It is limited to use of a visual analog scoring, or 
numeric rating, with the gait of each animal being assigned a score [7]. There appears to 
be no validated standards for objective gait analysis in goats. Limitations associated with 
subjective gait analysis are numerous and include inter-observer variability, lack of a 
validated standard scoring system, and limitations associated with analysis of categorical 
data [8-12]. In other livestock species, such as cattle and horses, subjective visual 
assessment is shifting to objective assessment [13-16].  
Objective lameness assessment currently relies on sensor technology, such as 
pressure sensing systems, force plates, accelerometers, and kinematic studies with 3D 
motion capture technology [16]. Devices used to monitor lameness are important tools 
that need to be precise and accurate [17]. Studies have shown that certain kinetic 
measurements may differ based on the device that is implemented, or even the method by 
which it is calibrated [18]. Weight bearing provides an important tool for assessing the 
functional use of the limbs. Most studies using objective gait assessment are aimed at 
gaining information related to lameness [14]. Lameness assessment research often is 
focused on the detection of severely lame animals, with less precision given to mild 
lameness [14]. Even minor dairy species, such as Mediterranean buffalo, are beginning to 
be looked at objectively for lameness, but problems arise with sensors that short, as 
continuous strides may be missed with a limited algorithm [19].  
Difficulties associated with objective lameness technology become particularly 
relevant in orthopedic research, when new material or devices may rely on lameness 
assessment as an outcome parameter in terms of animal welfare [3, 4]. Many studies rely 
on subjective lameness scoring systems, only mention monitoring lameness post-
operatively, and/or rarely report findings of lameness in study conclusions [20-22]. While 
several studies exist describing objective lameness outcomes in relation to orthopedic 
research, few are done from a basis of described normal variables available for that 
specific species [23, 24].  
Advantages to pressure-sensing systems with walkways are that they are time 
efficient, can evaluate multiple sequential steps, and have the ability to evaluate the 
contralateral limbs within the same walking pass and in the same trial [18]. Although 
originally used in biped gait analysis, pressure-sensing mats have been used to study gait 
in multiple species, such as horses, cattle, turkeys, sheep, pigs, dogs, and cats [17, 18, 23-
30]. However, few studies validate these measurements or describe normal biometric 
variables [17, 31]. In one study, normal intact Santa Ines sheep were evaluated using a 
pressure-sensitive walkway and a 3-camera kinematic system, which allowed for normal 
parameters to be described for varying age groups [31]. Literature describing pressure 
sensitive platforms for use in the biometric assessment of lameness has been described, 
but is lacking for goats initially free of lameness [32, 34]. Sheep and goats are important 
34 
 
models for orthopedic research and share many similarities [4]. Some aspects of gait 
analysis in sheep require more comprehensive assessment tools because of their flight 
zone and flocking behavior. These limitations can be addressed with training [4].  
The purpose of this study was to quantitatively assess biometric variables of gait 
and associated forces during ambulation in goats free of lameness. We hypothesized that 
goats could be trained to walk across a pressure-sensing walkway to allow consistent 
recording of data for variables of stride, gait, and force. The objectives were to describe 
the characteristics associated with stride and weight-bearing force in goats free of 
lameness, thereby providing a baseline for future studies using a pressure-sensing mat 
investigating lameness. This information will not only benefit the veterinary community 
in providing a baseline for goats free of lameness, which may be applied to herd health 
lameness monitoring programs, but will provide a valuable set of gait parameters for 
goats as a reference in the design and conduction of orthopedic research where lameness 
is induced or is a concern.  
 
Materials and Methods 
Goats 
All study procedures were approved by the University of Tennessee Animal Care 
and Use Committee (protocol number 2383). Forty-six mixed breed goats between five 
and six years old and weighing 52 ± 7.1 kgs (range 40-69 kgs) were purchased from a 
licensed, commercial vendor. Goats were a mixed breed population, including Boer, 
Spanish, Nubian, Saanen, Oberhasli, and hybrid goats. Goats were judged to be free of 
lameness based on a visual lameness score of 0 (normal movement) out of 4 [2]. Hooves 
and feet were inspected, and hooves were trimmed to ensure all goats had normal and 
consistent conditioned feet. Goats were housed in groups of five to six in small pens (15 
ft2 per animal) (National Research Council. Guide for the care and use of laboratory 
animals; National Academies Press, 2010). Flooring included a layer of wood shavings 
(2.5 to 5-cm thick) laid on top of rubber mats placed on top of a concrete floor in a 
conditioned housing facility for the duration of the study. They were fed a total mixed 
ration, provided access to hay as an environmental enrichment, and given access to 
automatic waterers to meet nutritional and metabolic requirements. Goats were weighed 
at study entry and exit to monitor nutrition and health.  
Data Collection 
After confirming that all goats entering the study were free of lameness (VLS 
score of 0), gait parameters were objectively assessed by evaluating measurements 
obtained from an automated, real-time pressure sensing system (Walkway Pressure 
Mapping System, Tekscan Inc, South Boston, MA). The sensor matrix was 87.1 cm long 
by 36.9 cm wide and had a sensor density of 1.4 sensors/cm2. The mat was calibrated and 
equilibrated according to the manufacturer’s instructions. Triggering was enabled so that 
recordings would start at the first contact, or a raw sum force of 200 kPa, and end at total 
of 400 recorded frames at a rate of 15 frames per second. An alleyway was assembled in 
order to create a fixed walkway for the goats. The pressure mat was placed in the 
midpoint of the alleyway and covered with a soft, rubber overlay to create a consistent 
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visual and tactile flooring with good footing for the testing area (Fig 2-1).2 The width of 
the alleyway was made such that goats could move freely in a straight line, would be 
discouraged from turning around, and that each goat’s footfalls would strike the sensitive 
area of the mat. Prior to initiation of the trial, goats were individually weighed using a 
digital scale. Goats were then fitted with a halter and led at a walking pace across the 
pressure-sensing mat, with an investigator sitting to the right of the mat adjacent to the 
constructed alleyway. The halter and lead were useful to encourage goats to pass through 
the walkway without stopping. During the study, no tension or pressure was applied to 
the halter to ensure that no changes in head movement or gait occurred.  
Biometric assessment of gait was collected from the 2 best-fit recording in one 
direction, on each of 2 separate days (day 0 and 3). Each goat was walked across the mat 
up to 5 times (5 passes) until at least 2 valid walking passes were obtained. A pass was 
considered valid if the goat maintained a progressive walking gait, had a VLS of 0 during 
the pass, walked calmly through the alleyway without stopping or resisting walking 
forward, walked over the walkway without distraction, and if all four limbs had contact 
with the pressure sensing surface of the walkway. The data from the first two valid passes 
on each day were recorded and averaged for each goat, allowing for one set of data to be 
analyzed for each day.  
Data was discarded during the data acquisition phase of the study if any goat 
hesitated, changed their gait or pace, or reacted to surroundings in a way that altered their 
gait. Acceptable behavior was limited to a subjectively assessed lameness score of 0, and 
walking in a forward manner without distraction from the investigator or hesitation from 
the halter and lead. Each pass was recorded with a digital video camera to record 
extremity strike and gait as the goat walked over the pressure sensor mat, and data from 
the mat sensor were transmitted to the system’s computer software (Microsoft LifeCam 
Cinema, Microsoft Corporation, Redmond, WA). The frame rate of the video camera was 
adjusted to 15 frames per second to match the pressure-sensing mat. Once data was 
transmitted to the software it was then exported to Microsoft Excel, backed up, and stored 
within an external hard-drive (Microsoft Excel for Windows 10, Seagate Portable 1TB 
External Hard Drive USB 3.0, USA). Due to significant range in the mixed breeds of the 
goats (Boer, Spanish, Nubian, Saanen, Oberhasli, and true mixes) and various limb 
lengths, it was necessary to average two valid passes to obtain consecutive footfalls, 
allowing for a complete data set for one valid run per day. Data sets were included in 
statistical analysis if they were complete for all variables.  
Gait Variables 
Gait variables included the number of stance (or footfalls), gait time-front (sec), 
gait distance-front (cm), gait velocity-front (cm/sec), and cycles per minute. Stance and 
stride variables measured included stance time (sec), swing time (sec), stride time (sec), 
stride length (cm), stride velocity (cm/sec; Table 2-1). With goats that had long swing 
times, stride times, and/or stride lengths, multiple passes were required to obtain one 




2 All figures and tables for this chapter are presented in the appendix. 
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valid run; therefore, the first two valid passes that allowed a complete data set were used 
in the analysis. 
Force Variables 
Measurements of force variables included maximum force (Kg), maximum force 
normalized to body weight (%BW), impulse (Kg*sec), impulse normalized to body 
weight (%BW*sec), and maximum peak pressure (KPa). Maximum force (Kg) was the 
maximum force recorded during the stance phase of each extremity. Maximum force 
(%BW) was defined during the stance phase of the given extremity (normalized to the 
animal’s body weight). When there were multiple stances within the same pass, the 
maximum force values for that extremity were averaged. Impulse (Kg*sec) was the 
average of all foot strikes for the given extremity. Impulse (%BW*sec) was the average 
impulse of all foot strikes for a given extremity and normalized to body weight. Finally, 
maximum peak pressure (kPa) was defined as the peak force per unit area for a given 
extremity. To our knowledge, this device has not been validated for mixed breed goats 
with a significant range of weights; we present descriptive data for this population. 
Statistical Analysis 
 Descriptive statistics for each parameter were generated, including the mean, 
standard deviation, and minimum and maximum values (IBM SPSS 25, Armonk, NY). 
Each gait parameter was analyzed with a Shapiro Wilk test to evaluate for normality of 
distribution (p-value > 0.05). An appropriate parametric student t-test or nonparametric 
Wilcoxon rank sum was performed for each variable between days to evaluate for 
repeatability between days. A one-way ANOVA followed by Tukey’s post-hoc test was 
performed to compare gait parameters between limbs. For variables that were not 
normally distributed, a one-way Kruskal-Wallis test followed by a pairwise comparison 
between limbs with a Dunn-Bonferroni correction to compare gait parameters was 
performed. A sample size estimate to detect the effect of time and extremity with 80% 




Out of 46 goats, 33 (72%) met the inclusion criterion for analysis. Goats readily 
walked through the alleyway and across the pressure-sensing mat system without 
difficulty. Thirteen goats were removed from statistical analysis because of having 
incomplete data sets (lack of 2 valid passes within a maximum of 5 attempts). Due to the 
range in stance time (sec), swing time (sec), stride time (sec), and stride length (cm), it 
was necessary to average two valid passes to obtain consecutive footfalls for a complete 
data set for each test day. After the repeatability assessment, data was then pooled. 
Pooled data for stance-stride variables were tabulated (Tables 2-2 and 2-3). Descriptive 
statistics for gait variables are reported as the means ± standard deviation and range 
(minimum, maximum) for 33 goats having complete datasets. The mean number of 
stances was 9.03±1.81 (6.00, 14.00). The gait-time front (sec) was 1.73±0.72 (0.51, 4.10), 
the gait distance-front (cm) was 132.38±13.92 (96.90, 153.00), and the gait velocity-front 
(cm/sec) was 92.64±36.30 (34.40, 279.60). The mean gait cycle time (sec) for 33 goats 
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was 1.00±0.25 (0.44, 2.00), while the mean cycles/minute was 64.67±15.62 (30.00, 
139.00).  
Data that were normally distributed included maximum force (%BW), maximum 
force (Kg), stride length (cm), and maximum peak force (KPa; p > 0.05). Of those 
parameters, maximum force (%BW), maximum force (Kg), and maximum peak force 
(KPa) were significantly different among the limbs (p < 0.001).There was no significant 
difference in stride length (cm) among the limbs (p > 0.05). As the gait parameters 
maximum force (%BW), maximum force (Kg), and maximum peak force (KPa) may be 
most associated with future orthopedic or animal welfare studies, they were selected for 
the sample size estimate analysis to detect the effect of time and extremity. Based on 
these variables, only 12 animals were needed to detect the effect of time and extremity.    
 When evaluating day 1 versus day 3, there were no significant differences for the 
variables maximum force (%BW), maximum force (Kg), impulse (%BW *sec), impulse 
(Kg*sec), or maximum peak pressure (KPa; p > 0.05) for any of the extremities. There 
was a day-effect for the variables stance time, stride time, stride length, and stride 
velocity. For the variable stance time (sec), there was a significant decrease in time for 
the majority of goats (n = 21, left front; n = 23, right front; n = 23, right hind) on day 3 as 
compared to day 1 (p < 0.05). For the variable stride time (sec), there was a significant 
decrease in time for the majority of goats (n = 19) on day 3 as compared to day 1 for the 
right hind limb (p < 0.05). For the variable stride length (cm) there was a significant 
difference for the left front and right front means with the left front being greater on day 
3 versus day 1 and the right front mean being greater on day 3 versus day 1 (Table 2-3; p 
< 0.05). For the variable stride velocity (cm/sec) there was a significant difference for all 
extremities on day 1 versus day 3, with the means for the left front being greater on day 
3, the means for the left hind being greater on day 3, the right front means being greater 
on day 3, and the right hind means being greater on day 3 (p < 0.05; Table 2-4). The 
mean stride length (cm) was greater on day 3 as compared with day 1 for the left front 
limb and right front limb (p < 0.05). The left hind and right hind limb means are reported 
with * as they were not significantly different between days. The mean stride velocity 
(cm/sec) was greater on day 3 as compared to day 1 for all extremities (p < 0.05).  
 Within paired limbs, there were no significant differences between the means of 
the left front and right front limbs, nor the left hind and right hind limbs, respectively (p > 
0.05). Significant differences were found for maximum force (Kg) between the limbs. 
There was a significant difference between the left front and hind limbs with the left front 
mean being greater than the left hind and right hind limb (p < 0.001). There was a 
significant difference between the right front limb and the hind limbs with the right front 
limb being greater than the left hind and right hind limb (p < 0.001; Fig 2-2B). 
Significant differences were found for maximum force (normalized to %BW; p < 0.001) 
between the limbs. There was a significant difference between the left front and left hind 
and the hind limbs with the left front mean being greater than the left hind and right hind 
limb (p < 0.001). There was a significant difference between the right front and the hind 
limbs’ weight, the right front mean being greater than the left hind and right hind limb (p 
< 0.001; Fig 2-2A). A significant difference was found between the limbs for maximum 
peak pressure (kPa). The left front limb was significantly greater than the left hind and 
right hind limb (p<0.001). The right front limb was greater than the left hind and right 
hind limb (p < 0.001; Fig 2-2C).  
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No significant differences were found between the extremities for the gait 
parameters stance time (sec), swing time (sec), stride time (sec), and stride velocity 
(cm/sec; p > 0.05). Significant differences were found among between the extremities for 
the gait parameters impulse (%BW*sec) and impulse (kg*sec; p < 0.001). Impulse was 
significantly less for the paired hind limbs compared with the paired forelimbs (p < 
0.001; Fig 2-3B). The impulse normalized to percent body weight was significantly less 
for the paired hind limbs compared with the paired forelimbs (p < 0.001; Fig 2-3A).  
 
Discussion 
In the present study, we were able to quantitatively assess biometric variables of 
gait and associated forces during ambulation in goats free of lameness. We found that 
goats could be quickly trained to walk across a pressure-sensing walkway, allowing 
consistent recordings of data for variables of stride, gait, and force. Based on the results 
of this study, we found that data derived for stride variables is more susceptible to 
variations when assessments are done at multiple time points. Also, front limb and rear 
limb assessments should be evaluated separately when using force variables to serially 
evaluate goat ambulation. We were able to describe the characteristics associated with 
stride and weight-bearing forces in goats free of lameness. Thus, the consequences of this 
study are important in that they provide a baseline for future studies using a pressure-
sensing mat investigating lameness.  
Detailed knowledge of gait characteristics in goats may benefit the veterinary 
community in that lameness evaluation of small ruminants may now be more easily done 
at an objective level, allowing this technology to potentially be used in herd health 
situations. Our results suggest that biometric pressure sensing may be a useful tool for 
gait assessment in goats regardless of breed. Using a pressure sensing system, we were 
able to quantitatively assess gait and biometric forces during ambulation in goats free of 
lameness using a pressure-sensing mat as a biometric tool for gait analysis. It is important 
to note that baseline clinical health examinations were not included as confounding 
variables in this study. Due to our interests in orthopedic research, which typically do not 
include infirmed, immature, or geriatric animals, we limited our population to young, 
skeletally mature goats free of lameness [1]. It was assumed that this population included 
mainly healthy goats. Currently, we do not have baseline values for goats that are 
clinically evaluated to be ill or outside the skeletal range we have evaluated. Future 
studies would need to include a correlation between visual lameness scores and 
alterations from the baseline values reported here  
Pressure sensing systems evaluate ground reaction forces where pressure causes 
activation of the sensors [34]. Quantitative measurements may be useful to determine 
functional weight bearing and to assess changes in acute weight bearing or for serial 
evaluation of pain [35] The number of walking passes needed to obtain valid data sets 
may vary; we were able to obtain data using the pressure sensing walkway set-up within 
an alleyway with relatively few repeated walking trials [36]. We were successful in being 
able to collect complete data sets with relatively few passes in the majority of goats 
tested. The pressure-sensing mat was useful to measure functional gait characteristics 
even in the face of a nonhomogeneous population. With minor variations, the biometric 
data acquired was useful for statistical analysis within walking trials and between trial 
days allowing for pooled analysis. The walkway system provided a means of collecting 
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valuable data with limited training while using a more realistic animal model population. 
Additionally, when weight bearing is used as an outcome variable, this accurate 
quantitative tool may help in power calculations of treatment group size when designing 
animal experiments.  
 Some caution may be warranted when evaluating the parameters stance time 
(sec), stride time (sec), stride length (cm), and stride velocity (cm/sec) between days, as 
these variables were not always repeatable between days among the extremities. This is 
particularly true for stride velocity (cm/sec), which was not repeatable for any limb 
between days. A solution to this in the future would be to standardize for stride velocity 
(cm/sec) as has been reported for other walkway assessment tools [31]. As we used a 
nonhomogeneous population, this standard was not met. A previously published study in 
which dogs of various sizes were allowed to walk with their preferred velocity, reliable 
gait assessment was obtained, indicating that perhaps standard velocity may not be 
necessary when assessing gait parameters for lameness [33]. Despite this limitation, we 
were able to obtain valid results that should be acceptable as quantitative data for gait 
analysis even when performed serially over time. One potential confounding variable is 
that the investigator was placed on the right side of the mat. Goats tended to walk closer 
to the left side of the mat, opposite from the data acquisition station. Similar to sheep, 
goats are prey species animals and tend to shy away from human contact [5, 11, 36]. This 
contributed to 13 goats being eliminated from the data set, as their behavior was 
unacceptable in that they were unable to walk forward without distraction or hesitation. 
This is consistent with dogs being walked on a leash and leash side influencing gait 
symmetry [33]. In these goats, multiple passes were discounted because of walking more 
quickly than desired or stopping halfway across the pressure mat. Additional training, 
such as walking in either direction, acclimatization, or a different alleyway system for 
acquiring ambulatory data, may help normalize this data. Despite goats being removed 
from study, significant results were able to be retained, similar to a pressure sensing study 
with turkeys [27]. While not all birds were available at all time points, significant results 
were able to be obtained indicating that data may be pooled for herd populations and gait 
parameters may be evaluated over time [27]. Finally, goats have relatively small hooves; 
therefore, using a pressure mat with a greater sensor density may improve precision and 
accuracy of weight bearing data.  
Similar to other studies, we found that maximum force (Kg), maximum force 
normalized to body weight (%BW), and maximum peak pressure (kPa) was greater in the 
forelimbs than the hind limbs when measured using a pressure-sensitive walkway [31]. 
This is valuable for orthopedic research when using small ruminant models to establish 
methods for objective, quantitative assessment of weight bearing and gait [17, 31]. 
Providing a tool to supplement subjective VLS evaluations with objective data will allow 
more robust monitoring and assessment of gait in research subjects. The importance of 
providing an objective standard for lameness assessment in orthopedic models cannot be 
understated. Measuring weight bearing in fracture models is an expected standard of care; 
however, there remains a deficiency of literature on the topic [37]. Current animal use 
protocols, in general, use subjective measurements because of ease of application and 
lack of access to objective alternatives [38-41]. Moving towards nonbiased objective data 
is expected to benefit animal welfare and improve the quality of quantitative data in the 
use of small ruminants as models for orthopedic disease.  
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No validated visual or objective lameness assessment system exists for goats. 
Categorical assessment tools are subject to bias interpretation and must be analyzed using 
statistical tests for categorical data, making them less sensitive at identifying differences 
[5-12]. Difficulties with subjective data include inter-observer differences, limitations of 
categorical data, and lack of a standard scoring system for the species. Inter-observer 
differences have long been noted in lameness research in horses [41]. Objective 
assessment tools offer the possibility of validating subjective tools for use in research, 
which is currently limiting [41]. Analysis of categorical data, such as VLS scores, are 
challenging even after transformation to proportional (categorical) data and can yield 
spurious results [41]. Categorical data, therefore, requires different methods for analysis 
that may be less sensitive than objective, continuous data obtained with tools, such as 
pressure mat sensing systems [42]. Variability in subjective scoring systems, comparing 
lameness scores across any type of research model of lameness, becomes inherently 
problematic at a time where there is a call for large animal models to become more 
standardized [43, 44]. Other alternatives include the use of accelerometers to measure 
activity and define 3D gait characteristics, such as height of excursion of the limb/foot. 
These technologies are less adaptable to real-time analysis and assessment [37]. 
In the present study, we quantitatively assessed gait and biometric forces during 
ambulation in goats subjectively free of lameness using a pressure-sensing mat as a 
biometric tool for gait analysis. The pressure-sensing mat is an objective tool, free of 
inter-observer differences, and easy-to use. In an era where scientific procedures 
involving the use of animals is at an all-time low, the importance of providing stress free, 
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Figure 2-1. Examples of halter-lead training and sample gait analysis. 
(A) Pressure-sensing walkway placed in an alleyway system with soft mats and loose 
halter and lead for training. (B) Example of gait analysis with goat walking across 
pressure- sensing matrix placed in the alleyway system in the lower left-hand corner. The 
video recording with strike boxes is present in the upper left-hand corner, the stride stable 


















Table 2-1. Working definitions used for gait variables.  
 
Gait Variable  Definition  
Number of stances The total number of stances (footfalls) taken by the animal. 
Gait time-front (sec) The time of first contact of the given front extremity stance 
to the time of first contact of the last given extremity stance 
as registered on the sensor. 
Gait distance-front (cm), 
or length unit, 
The gait distance measured along the line of progression, 
from posterior of the given front extremity stance to 
posterior of the last given extremity front stance. 
Gait velocity-front 
(cm/sec) 
The gait distance divided by the gait time. 
Gait cycle time (sec) Began with the first contact time of the given front 
extremity fall to be valid on the sensor. Time was 
measured to the first contact of the next instance of that 
given extremity striking the sensor. 
Cycles per minute The number of complete gait cycles per minute, or gait 
cycle time divided by sixty.  
Stand-Stride Variable Definition 
Stance Time (sec) The weight-bearing period, was defined as the time from 
first contact to last contact of a given extremity in seconds. 
Swing Time (sec), The non-weight bearing period, was defined as the elapsed 
time between the last contact of a preceding and the first 
contact of the next of two consecutive footfalls of a given 
extremity. When there were no consecutive footfalls, no 
data was recorded. 
Stride Time (sec) The elapsed time between the first contacts of two 
consecutive footfalls of a given extremity. If there were no 
consecutive footfalls, no data was recorded. If there were 
multiple strides within the same pass, times were averaged. 
Stride Length (cm) The distance measured parallel to the line of progression 
between the posterior heel points of two consecutive 
footfalls of a given extremity. When there were multiple 
strides, the lengths were averaged. 
Stride Velocity (cm/sec) The stride length divided by the stride time for the given 
extremity. When there were multiple strides, the velocities 






Table 2-2. Descriptive statistics for the stance gait parameters. 














Limb Mean ± SD 
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Table 2-3. Descriptive statistics for the stride gait parameters.  
























Limb Mean ± SD 
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Table 2-4.Student’s t-test evaluating day 1 versus day 3.  
 
Extremity 







1 Day 3 
Mean 
+/- SD Day 1 Day 3 
Mean 
+/- SD Day 1 Day 3 
Mean 





(cm) 78.07 85.83 7.76 +/- 78.82 88.81 9.99 +/- 75.97 78.48 
2.51 +/-
* 74.58 81.75 7.17 +/-* 
Stride 
Velocity 
(cm/sec) 79.91 100.35 20.44+/- 81.34 103.25 21.91 +/- 75.79 94.62 
18.83 
+/- 74.72 95.21 20.48 +/- 
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Figure 2-2. Box plots for Maximum Force (%BW), Maximum Force (Kg), and 
Maximum Peak Pressure (KPa). 
The line in the middle of each box represents the median value for each extremity for 
each variable. Outliers are represented as circles. (A) Maximum force (%BW) shows that 
the paired left front and right front means are greater than the left hind and right hind 
means (p < 0.001). (B) Maximum force (Kg) shows evidence that paired left front and 
right front means are again greater than paired left hind and right hind means(p < 0.001). 
Finally, in panel (C), Maximum Peak Pressure (kPa) is shown to be significantly different 
among the extremities with the paired forelimbs being greater than the paired hindlimbs 
(p < 0.001).  
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Figure 2-3. Box plots for Impulse (%BW*sec) and Impulse (Kg*sec).  
The line represents the median value for each extremity for each variable. Upper and 
lower quartile ranges are shown and the entire range is represented by lines (whiskers) 
with outliers being represented as circles either above or below the whiskers. (A) Impulse 
(%BW*sec) is significantly greater for the paired forelimbs than the paired hind limbs (p 
< 0.001). (B) Impulse (kg*sec) is significantly greater for the paired forelimbs than the 




CHAPTER 3.  
ASSESSMENT OF OSSEOINTEGRATION OF A NOVEL SYNTHETIC BONE 













































Treatment of debilitating long bone fractures have yet to find a suitable synthetic 
scaffold replacement to the gold standard bone autograft. In this study, the long term 
ability of a multi-layered polyurethane-nanohydroxyapatite-decellularized 
(nHA/PU/DBP) bone particle scaffold to repair long bone ostectomy defects is 
investigated in a large animal model. Data presented is in a clinically relevant large 
animal bone healing model over a 12 month period of time. Based on radiographic, 
computed tomographic, and load-to-failure analysis, all treatment groups healed over 
time. Dual energy x-ray absorptiometry showed greater bone mineral density for goats 
treated with scaffold and scaffold plus bone morphogenetic protein-2 (BMP-2) groups. 
Histomorphometric analysis showed greater osteoid formation for scaffold and BMP-2 
goats, while mineralization and osteoclast numbers were consistent with bone remodeling 
over time. Low morbidity and mortality associated with the preclinical large animal 
model presented here show the potential for this model to become standardized for 
ostectomy gap healing. The use of a nHA/PU/DBP scaffold with the addition of BMP-2 
































The use of regenerative therapies for human musculoskeletal defect injuries is on 
the verge of becoming standard practice. [1] Traditionally, catastrophic fractures have 
required the use of bone grafts when a decision has been made to salvage a limb [2, 3]. 
The gold standard for bone grafting materials has been the autograft (bone taken from the 
patient’s own body) or the allograft (cadaveric bone from a bone bank) [4, 5]. The 
procedure is not without complication. Approximately 30-60% of grafting procedures 
result in one or more complications, ranging from infection to incomplete integration and 
donor site pain [6]. In humans, the incidence of non-union fractures is approximately 5-
10% [7]. The consensus for the definition of delayed healing or fracture non-union is 
inconsistent and subjective [8]. Musculoskeletal injuries have been reported to 
compromise approximately 50% of all combat wounds and are becoming an orthopedic 
burden of disease highlighting the need for approval of new regenerative therapies that 
will lower the incidence of these costly injuries [9-11].  
Development of a wide variety of synthetic materials has been undertaken in an 
effort to improve healing of debilitating factures [4]. An ideal regenerative material 
would be both osteo-inductive (provide a biologic stimulus for cells to differentiate into 
mature osteoblasts) and osteo-conductive (promote bone apposition or function as a 
receptive scaffold to enhance bone formation) [4]. Bio-ceramics such as calcium 
sulphate, tricalcium phosphate and hydroxyapatite are early products developed for use as 
synthetic grafting materials with extensive history of safety data [4, 5]. The combination 
of decellularized bone particles in combined with nano-hydroxyapatite impregnated 
polymer has been shown to be cyto-compatible and causes a substantial increase in 
osteoblast proliferation in vitro [12]. To date, an effective material to promote bone 
healing in large defects has yet to be constructed and in- vivo studies, especially in large 
animal preclinical models are lacking [6, 13]. 
Few studies have looked at bone regeneration and healing in animal study models 
exceeding ninety days [14]. Even fewer studies have used large animals, which are more 
translatable to humans [15-17]. The reasons for lack of large animal studies vary with the 
most common being expense [18]. The ability to generate validated data to meet Food 
and Drug Administration and International Organization for Standardization [ISO] 10993 
for new medical devices, such as a bone regenerative material or scaffold, require a 
relevant preclinical segmental bone defect in a large animal model to ensure the safety 
and efficacy of the material [6, 19]. When selecting a large animal model, the cost to 
acquire the animal, the care for the animal, the availability of the animal, society’s 
acceptance of the animal model, the animal’s tolerance to captivity and the ease of 
housing must all be considered [13, 14, 20]. In light of these hurdles, goats are an ideal 
animal for the study of bone regeneration.  Furthermore, the sequence of cellular events 
during osseointegration of grafting material has been shown to be similar in goats and 
humans [6, 14]. Historically in the evaluation of a new biomaterial, tibial fracture gap 
sizes have been made with a length of 2.0-2.5 times that of the shaft diameter, and are 
typically 20 to30 mm in length [6, 18, 19]. These segmental bone defects have been 
stabilized during the study period with a variety of acceptable fixation methods, ranging 
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from external fixator pins, bone plating, and intramedullary nailing, each with its own 
unique set of complications [6].  
Recently, a 3D bio-scaffold composed of polyurethane(PU)-nano-
hydroxyapatite(nHA) manufactured with 80% PU/nHA interspersed with decellularized 
bone particles exhibited promising  new bone formation in vitro and in rat models [12, 
21]. The combination of nHA/PU has been explored in-vitro and in small animal models 
[22, 23]. Selection of hydrophilic polyurethane as a candidate for scaffold fabrication 
offers suitable characteristics including biocompatibility, mechanical flexibility, and its 
bioresorbability [24-26]. Nano-hydroxyapatite has been combined with a variety of 
synthetic polymers to better mimic the mineral component and the microstructure of 
natural bone [27]. The ideal for the nHA/PU composite is to serve as a 3D substrate for 
cell attachment and migration, and in our lab we have demonstrated that the addition of 
decellularized bone particles further stimulates this integration with native tissue [21, 27].  
Hypothetically, the addition of a growth factor such as recombinant human bone 
morphogenetic protein-2 (rhBMP2) classically produced by E. coli or by hamster oocyte 
cell cultures, to the 3D scaffold could further stimulate bone formation. Bone 
morphogenetic protein-2 is a growth factor in the transforming growth factor beta 
superfamily with activity that was first identified in the 1960s [28, 29]. It is known for its 
osteoinductive capacity [29]. Large amounts of BMP-2 are difficult to produce and 
extremely costly [30]. Also, there is increasing evidence of deleterious side effects of 
associated with off-label use of hamster oocyte derived rhBMP-2 products despite its 
ability to elicit a consistent osteogenic effect [31]. Exaggerated bone response may be 
associated with the large initial release of the protein from various BMP-2 carrier devices 
[32, 33].  While the majority of recombinant human BMP-2 (rhBMP-2) is traditionally 
derived from Chinese hamster ovary cells, E. coli derived rhBMP-2 has been shown to 
show compatible fusion rates [30, 34-36]. E. coli derived rhBMP-2 is more cost effective 
and has shown potential as a growth factor capable of elution from scaffolds with a pore 
size of 100-300 um [34]. In typical fractures, BMP-2 is upregulated for up to 4 weeks 
following injury, supporting the idea that an alternative strategy is to have a sustained 
release of physiologically appropriate BMP-2 allowing for enhanced osteogenic 
differentiation while mitigating untoward side effects [32, 37-39].  
The aim of this project was to evaluate the long-term effect (up to twelve months) 
of a 3D synthetic bone regeneration scaffold, with and without the addition of E. coli 
derived rhBMP-2, implanted into a large segmental bone defect to assess the inherent and 
enhanced capability to promote bone formation [21]. For this purpose, we used a 2.5cm 
mid-diaphyseal tibia segmental osteotomy gap previously developed in our laboratory. In 
this model, we create and stabilize the defect using a custom designed and manufactured 
4.0-mm locking plate construct.  We hypothesized that the scaffold would promote bone 
formation without adverse effects, effectively deliver BMP2, and integrated and degraded 
over time. Our objectives were to assess the fracture model and the effect of the scaffold 
on the goats’ biometrics, bone healing, and scaffold degradation over a period of up to 1 
year.   
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Materials and Methods 
Scaffold Fabrication 
Multi-layered scaffolds were fabricated as previously described (Fig 3-1a) [12, 
21].3 Cylindrical scaffolds were manufactured to serve as a transmedullary implant 
(spanning the gap from proximal to distal medullary canals). As such they were 
manufactured to a length of 2.5 cm and a diameter of 8 mm to provide a secure fit into 
the intramedullary cavity of both the distal and proximal segments of the cut tibia. 
Scaffolds were sterilized using ethylene oxide prior to surgery.  
Study Design 
All experimental procedures and protocols were approved by the appropriate 
animal care and use committees (University of Tennessee IACUC 2383). Eighty-three 
mixed breed goats [2 to 6 years old, average weight 52.49±0.25 kgs (35-78 kgs)] were 
purchased from a USDA licensed vendor. Goats were group housed in pens with free 
access to grass hay, water, trace minerals and fed a daily total mixed ration [40]. Animals 
were acclimatized for a minimum of 10 days before surgery. The study design consisted 
of three groups: Control group: goats had the segmental defect without any treatment of 
the defect; Scaffold group goats had the native scaffold inserted in the gap; BMP-2 
impregnanted scaffold group goats had an rhBMP-2 impregnated scaffold inserted into 
the gap. In BMP-2 animals (scaffold + rhBMP-2), 1.5 mg of lyophyilized E. coli derived 
rhBMP-2 (BioVision, Milpitas, CA., USA) was impregnated into the scaffold for a 
minimum of 30 minutes prior to implantation Dosage of BMP2 was extrapolotaed from 
previous studies and clinical use products. Each group of goats were used to study 
regeneration and scaffold efficacy for 3, 6, 9, and 12 months. Each group at each time 
point included 8 goats (3 groups x 4 time points x 8 goats = 96 goats in total) with up to 2 
replacement goats per group per time point (n=24).   
Surgical procedure and scaffold implantation in caprine tibias  
Goats were withheld from feed for 24 hours, and water for 12 hours prior to 
surgery. Each goat was sedated with xylazine (0.05 mg/kg IV) and induced into general 
anesthesia using midazolam (0.25 mg/kg) and ketamine (5 mg/kg). Goats were then 
intubated and placed into dorsal recumbency under general anesthesia and maintained 
using isoflurane gas vaporized in 100% oxygen. Balanced anesthesia was carried out 
using monitoring parameters (heart rate, respiratory rate, temperature, response to 
stimulus) and isotonic fluids were provided at 10 ml/kg/hr. The right hind limb was 
suspended, clipped, and aseptically prepared for surgery. An approximately 20-cm linear 
incision was made over the medial aspect of the tibia. The periosteum was incised and 
reflected from the surface of the tibia. A custom designed, 8-hole, 4.0-mm thick, locking 




3 All figures and tables for this chapter are presented in the appendix. 
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plate was applied to the cranial medial aspect of the tibia. This custom designed locking 
plate (Veterinary Orthopedic Implants, St. Augustine, Fl., USA) had each of the locking 
screw holes placed at the ends of the plate (4 at each end) so as to ensure the section of 
the plate spanning the defect was solid and would prevent bending failure. Four 4.0-mm 
diameter locking bone screws were placed into each of the proximal and distal segments 
of the tibia spanning the region of the segmental ostectomy (Fig 3-1b). A 2.5-cm length 
full thickness segment was cut using an osteotomy saw and the bone segment removed 
from the tibia. The scaffold material was trimmed, using surgical scissors and/or a #10 
scalpel blade, to the appropriate length for the ostectomy (Fig 3-1c and d). The 
ostectomy gap was left unfilled in the Control group goats, was filled with scaffold 
material in the Scaffold group goats, or filled with an rhBMP-2 impregnated scaffold in 
the BMP-2 group goats. The subcutaneous tissues were closed with 2-0 polydiaxanone in 
a continuous pattern. The skin was closed using 0 polypropylene in a continuous pattern. 
A Robert-Jones splint bandage (Tarsal Real Leg Quick Splint, Large, Jorgensen 
Laboratories, Loveland, Co., USA) was placed on the limb to protect the surgery site 
during recovery and for 60 days after surgery. The goats received flunixin meglumine (1 
mg/kg IV; non-steroidal anti-inflammatory twice daily) for pain control for the first three 
days after surgery and received Ceftiofur sodium (2.2 mg/kg IV) for three days for 
antibiotic prophylaxis. Additional pain control was provided via a fentanyl transdermal 
patch (72 mcg/kg/hr) which was placed on the dorsal lateral thorax 18 hours prior to 
surgery and continued for 3 days post-operatively. When needed based on attitude, 
activity and lameness, additional analgesic were given (meloxicam 1 mg/kg orally one 
daily and/or fentanyl transdermal patches 75 mcg/kg/hr) as needed. The goats had free 
access to food and water post-operatively, and were monitored for morbidity daily. Splint 
bandages were changed daily for the first 5 days, then every other day for two weeks, 
then weekly for two months. Splint bandages were removed at two months. Goats were 
housed in individual pens for the first 7 days post-operatively, then group housed in pens 
thereafter. Based on treatment group assignments, goats were euthanized at 3, 6, 9, or 12 
months post-operatively by intravenous overdose of a barbiturate (pentobarbital 1 
cc/10lbs).    
Lameness evaluation post-operatively  
Gait parameters, specifically right hind maximum force as a percent of body 
weight, were quantitatively assessed using a real-time pressure sensing system (Walkway 
Pressure Mapping System, Tekscan Inc, South Boston, MA). The sensory matrix was 
87.1 cm long by 36.9 cm wide and had a sensor density of 1.4 sensors/cm2. The mat was 
calibrated and equilibrated according to the manufacturer’s instructions. Triggering was 
enabled so that recordings would start at the first contact, or a raw sum force of 200 kPa 
and end at a total of 400 recorded frames at a rate of 15 frames per second. An alleyway 
was assembled to create a fixed walkway for the goats. The width of the alleyway was 
made such that the goats could move freely in a straight line, would be discouraged from 
turning around, and that each goat’s foot falls would strike the sensitive area of the mat. 
Right hind maximum force as a percent of body weight data was collected prior to the 
creation of the ostectomy gap, then at day 7 post-operatively and at monthly intervals 
until end points.   
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Imaging assessment of ostectomy gaps and scaffold integration 
 
High definition thermal imaging 
High definition thermal images were acquired post-operatively at days 2, 4, 6, 8, 
10, 12, 14, 21, 28, 35, 42, 39, 56, and then monthly until end points (Fluke Thermal 
Imaging, MSC Corporation, USA). The camera was held one meter away from the goat 
after the bandage had been removed and the limb had been allowed to acclimate to room 
temperature when a bandage was still in place. The thermal reading nearest to the 
ostectomy gap on the lateral aspect or craniocaudal aspect of the images were kept to the 
nearest Farenheight degree. 
Radiographic assessment 
 Radiographs were performed immediately post-operatively and then monthly until 
end points (NEXT Equine DR, Sound, Carlsbad, CA., USA). Radiographs were scored 
by a board certified radiologist to assess ostectomy gap filling Table 3-1. For statistical 
analysis, a score of 5 was equal to that of a healed fracture (ostectomy gap completely 
filled with new bone and/or bridging callus present on all cortices). 
Dual energy x-ray absorptiometry (DEXA) 
 A dual energy x-ray absorptiometry (DEXA) was performed immediately post-
operatively then monthly until end points (Hologic QDR 4500, Horizon DXA Systems, 
Marlborough, MA., USA). Briefly, the goat was sedated (xylazine 0.05 mg/kg IV) and 
placed in sternal recumbency, the hind limbs were extended, and the right hind limb was 
scanned using the lumbar spine settings. A region of interest (ROI) was drawn over the 
osteotomy gap and bone mineral content (g) and bone mineral density (BMD; g/cm2) 
were calculated. 
Computed tomography  
After humane euthanasia, the locking plate was removed from the right tibia. The 
goat was placed in dorsal recumbency and a computed tomography (CT) scan performed 
(Philips brilliance-40, Philips International B.V., Amsterdam, Netherlands). Transverse 
images were reconstructed in 2 mm slice thickness using high definition resolution, and 
sagittal and dorsal multiplanar (MPR) images were generated. ROI’s were drawn over 
either new bone, or density of the graft and calculated in Hounsfield units (HU). 
Biomechanical testing 
Once CT imaging was complete, the tibia were harvested, isolated, and prepared 
for a 4-point bending test. Testing was carried out using an Instron 5965 
electromechanical universal testing system coupling with a 5 kN maximum actuator 
(Instron 5965, Norwood, MA., USA). Testing was done in a single load-to-failure 
fashion.  The tibia and load points were optimally positioned such that the ostectomy site 
was at midpoint between both the inner and outer arms. Tibias were mounted on the 
holding grip with span set at 170 mm while the loading points were set at a span of 70 
mm. The testing was performed at a rate of 60 mm/min until the specimen failed. The 
mode of failure was recorded as bone fracture. The testing parameters were specified to 
61 
  
maximum load, expressed in kilograms of force (kgf), and it was defined as the 
maximum load applied by the actuator to the specimen during the test right before 
specimen failure. The displacement of the actuator was measured as a relative distance 
(mm) of the actuator to its’ original location at the start of the test. Tissue specimens 
lacking sufficient integrity to be mounted and tested were considered to have a value of 
“0” for the purpose of statistical analysis.   
Microscopic assessment of ostectomy gap and scaffold integration 
After 4-point bending tests were completed, tibia segments were trimmed and 
placed in 95% ethanol. Using an automated tissue processor (ASP300S, Leica, Germany) 
tissues were dehydrated in a series of ethanol solutions of increasing concentration (70%, 
80%, 95% x2, 100% x3) over a period of several days at ambient temperature and a 
programmed auto-cycle of pressure, vacuum, and gentle agitation. Specimens were next 
transferred to three separate exchanges of 100% Methyl Salicylate (Sigma-Aldrich, St. 
Louis, MO) over the course of 48-72 hours, manually cycled between gentle agitation 
(modified stir bar setup) and vacuum at -15-20 in Hg (Fisherbrand, Vacuum Chamber), 
and observed for complete dehydration. Specimens were transferred to 100% xylenes 
(Sigma-Aldrich, Histological Grade, St. Louis, MO) for a quick rinse before being placed 
back onto the automated tissue processor (ASP300S, Leica, Germany) for three changes 
of 100% xylenes to complete the tissue clearing and prepared for methyl methacrylate 
resin infiltration. Specimens were then manually managed through three separate and 
fresh in-house prepared Infiltration Solution (IS I, IS II, IS III) exchanges of methyl 
methacrylate (Sigma-Aldrich, St. Louis, MO) and dibutyl phthalate (Sigma-Aldrich, St. 
Louis, MO), under ambient temperature over the course of 1.5 - 2 weeks, and with a 
manually cycled switch between gentle agitation (modified stir bar setup) and vacuum @ 
-15-20 in Hg (Fisherbrand, Vacuum Chamber).  
After a satisfied period of resin infiltration, specimens were transferred to 
prelabelled polypropylene containers and pre-polymerized base molds, where a fourth 
and in-house prepared final resin solution was then added along with a benzoyl peroxide 
based catalyst (Perkadox-16, AKZO Nobel Chemicals, Chicago, IL) to initiate a 
polymerization reaction to cure each specimen into a bubble free, clear, hardened, methyl 
methacrylate (MMA) block over a period of approximately 5-8 days. Each specimen 
block was then trimmed using a wet bandsaw (MarMed Bone Wet Band Saw) so that 
resulting microtomed sections would fit onto pre-cleaned 50mm x 75mm glass 
microscope slides (Fisherbrand). Specimen blocks were shaped for microtomy and 
sections cut at five microns using a motorized SM2500 sledge microtome (Leica, 
Germany) and d-profile (sledge) tungsten-carbide knives (Delaware Diamond Knives). 
Each section cut was mounted to an individual 50mm x 75mm precleaned glass 
microscope slide (Fisherbrand) that was coated with an in-house gelatin based solution 
recipe (Haupt’s Solution) and covered with a plastic protective strip.  
Prior to staining, slide-sections from each specimen were sorted for VonKossa, 
Goldner’s Trichrome, Tartrate Resistant Acid Phosphatase (TRAP) staining, and 
fluorescence microscopy. The VonKossa stain was a silver stain that bound silver ions to 
the presence of calcium in boney tissue (undemineralized bone). It was developed 
chemically and visualized as a "jet-black" color identifying native/mature bone. The 
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process of osteoid, newly formed dense collagen, transitioning into mineralized bone was 
visualized as a black "peppering" throughout the greyish-blue osteoid layer on the surface 
of native/mature undemineralized bone. Goldner’s Trichrome staining and modified 
general bone and cartilage stain similar to Masson’s Trichrome staining, was used for a 
contrast between bone soft tissue morphology and the identification of dense 
collagen/osteoid (red) as compared to mineralized bone (green). Finally, Tartrate 
Resistant Acid Phosphatase (TRAP) staining (kit #387A, Sigma-Aldrich, St. Louis, MO) 
was employed to demonstrate the active presence of osteoclastic activity with actively 
resorbing osteoclasts being identified in red against a hematoxylin counterstained boney 
matrix. Prior to staining, all sections were deplasticized in a similar fashion that 
traditional paraffin sections would be deparaffinized so that all tissue components can be 
uninhibited during staining molecule interactions. 
To quantitatively assess the percentage of mineralization (VonKossa), osteoid 
formation (Goldner's Trichrome),  or osteoclast number (TRAP staining) images from 
each slide were grossly acquired and digitized using a Panasonic HC-V770 (8M, 
3264x2448, aspect ratio 4:3, extra optical zoom 20x)then processed in ImageJ (Rasband, 
W.S., Image J, U.S. National Institutes of Health, Bethesda Maryland, USA, 
https://imagej.nih.gov/ij/, 1997-2018.). For percentage mineralization, images were made 
binary such that mineralized bone was the parameter quantitatively assessed. For osteoid 
formation, images were made binary such that osteoid was the quantitatively assessed 
parameter. Finally, for the osteoclast number, osteoclasts per mm of bone surface were 
counted [41].  Unstained sections were evaluated by fluorescence microscopy with an 
excitation filter and two stop filters allowing radiation with a wavelength between 490 
and 520 nm that permitted the identification and morphometric analysis of the 
mineralizing surface of bone.  
Statistical analysis 
Statistical analyses were performed using separate mixed-model repeated-
measures analysis of variance within the GLIMMIX procedures of SAS to determine 
whether each outcome variable differed significantly by treatment group over time, with 
goat considered a random effect (SAS v 9.4, Cary, NC). Multiple comparison 
adjustments were made using Tukey’s post-hoc comparisons to assess the effects of 
group, time point, and group x time point interaction. For categorical variables, ordinal 
multinomial logistical regression doing a cumulative logit was performed by monthly 
analysis to determine if there were differences between treatments.  Significance was set 




  Goats were removed from study and replaced when necessary based on infection. 
Morbidity experienced with this model included osteomyelitis (n=13), plate bending 
(n=2), wound dehiscence (n=1), broken screws (n=2), anesthetic death (n=2), and sudden 
death of unrelated causes (n=2). A total of 83 goats (79%) were available for inclusion 




When evaluating maximum force as a percent of body weight for the right hind 
operated limb, there was no difference between groups. There was an effect of time in 
that goats were able to bear more weight through the operated limb (fracture healed and 
goats become “sound”) over time. The increase in pressure (kilograms force as a percent 
of body weight) exerted in the operated limb over time (19.16±1.26%BW) at 7 days post-
operatively) returned to baseline values pre-operatively (34.98±1.23%BW) showed an 
increased comfort during ambulation regardless of treatment group.  
Imaging assessment of ostectomy gap and scaffold osseointegration 
 
High definition thermal imaging 
The surface temperature at the site of surgery and scaffold implantation 
(ostectomy site on lateral or craniocaudal images) was not different between treatment 
groups regardless of time point. There was an effect of time in that surface temperature 
decreased (from 98 degrees Farenheit to 83 degrees Farenheit) over time, or that surgical 
site inflammation decreased and no additional inflammation was noted from fracture 
healing regardless of group. Alternatively, as the scaffold group and scaffold+BMP-2 
was not different from the control group, the addition of the biomaterial caused no 
additional detectable inflammation. 
Radiographs 
Radiographs for each goat were reviewed by a board certified radiologist (HS) 
blinded to the study groups assignments and scored for each month of study. The 
radiographic score of ostectomy gap filling was compared between groups and over time.  
A complete bridging callus was eventually formed in 73% of control goats, 66% Scaffold 
goats, and 79% of BMP-2 goats. Across all groups, there was a significant effect of time 
in that scores increased (ostectomy gaps healed) over time for all groups (P<0.05). There 
was no effect of treatment group on the ordinal probabilities for ostectomy gap filling at 
months 1-6, and months 10-12 (P>0.05). At month 7, there was an effect of treatment 
group on the ordinal probabilities for ostectomy gap filling (P<0.05). There were reduced 
odds in the Control group compared to the Scaffold group for lower ordered ostectomy 
gap filling scores (OR=0.159, CI 95%, 0.04-0.69), meaning that the Control goats 
showed greater gap filling scores (more healing) compared to Scaffold goats and BMP-2 
goats. At month 8, there were reduced odds in the Control group compared to the 
Scaffold group for lower ordered ostectomy gap filling scores (OR=0.133, CI 95%, 0.03-
0.60), and again at month 9 (OR=0.10, CI 95%, 0.02-0.49). Numerically, the odds ratio 
was 0.45 comparing BMP-2 goats to Scaffold goats for lower ordered ostectomy gap 
filling scores; however, the confidence interval ranged up to 1.67 and therefore was not 
statistically significant.  
Bone mineral density (BMD) 
Bone mineral density within the ostectomy gap was calculated for each goat at 
monthly intervals. Across all groups, there was a significant effect of time in that BMD 
within the ostectomy gap increased (ostectomy gaps healed) over time for all groups (Fig 
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3-3A; P<0.05). On average, BMD within the ostectomy gap was greater in Scaffold goats 
(0.93g/cm2 ±0.05) and BMP-2 goats (0.97g/cm2±0.05) as compared to Control goats 
(0.85g/cm2 ±0.05). A difference between groups over time approached significance 
showing that the BMD within the ostectomy gap was changing at a rate dependent on 
group (Table 3, P=0.057; Fig 3-3B). On average, the overall rate of change for BMD 
within the ostectomy gap showed similarities to a quadratic rate for bone healing. 
Computed tomography 
 When evaluating new bone density over time, there was a significant effect of 
time (P<0.05) with 3 month time-point goats, regardless of group, having less new bone 
density (1126.04HU ±47.71; P<0.05) than any other time-point [(6)-1331.27HU± 47.26, 
(9)-1262.97HU ± 72.83, (12)-1358.43HU ±44.06]. There was no significant difference 
between groups. When evaluating the density of the material, only Scaffold goats and 
BMP-2 goats were evaluated. On average, the density of the material was less (increased 
osseo-integration) in BMP-2 goats (612.17HU ±50.44) as compared to Scaffold goats 
(854.61HU ± 47.45; P<0.05, Fig 3-4). On average, both Scaffold goats and BMP-2 goats 
at twelve months had less density of the material, or more osseo-integration (550.66HU ± 
66.76), than all other time points [(3)-823.26HU ± 66.76, (6)-774.97HU ±75.63, (9)-
784.66HU ± 67.45; P<0.05]. 
Biomechanical testing 
4-point bending load-to-failure testing was performed in nineteen of twenty-six 
(73%) Control goats, nineteen of twenty-nine (66%) Scaffold goats, and twenty-two of 
twenty-eight (79%) BMP-2 goats (Table 3-2). Tissue specimens lacking sufficient 
integrity to be mounted and tested were considered to have a value of “0” for the purpose 
of statistical analysis.  Across groups, there was a significant effect of time (P<0.05). 
There was no difference between adjacent time points; however, consistent differences 
between the means for every 6 months of time in load-to-failure was apparent with load 
increasing over time in all groups [(3)-57.53kgf±36.32c, (6)-118.05kgf±28.49bc, (9)-
192.56kgf±26.10ab, and (12)-207.62kgf±23.87a]. There were no statically significant 
differences in load-to-failure between groups when bridging callus was achieved and 
mechanical testing was possible. On average, Control goats failed at 142.10kgf ± 25.19, 
Scaffold goats failed at 141.62kgf ± 26.94, and Scaffold+BMP-2 goats failed at 
148.09kgf ± 23.28.  
Microscopic assessment of ostectomy gap and scaffold integration 
Undecalcified bone segments slides were successfully processed for histology 
slides for analysis using stains for Von Kossa (n=78), Goldner’s Trichrome (n=79), and 
TRAP (n=69) staining evaluation. Additionally when available, slides for fluorescence 
microscopy were evaluated.  
Histomorphometry assessment of Von Kossa staining (percent area mineralized in 
the ostectomy gap), there was no significant difference between group, time point, and 
group by time point interaction (P>0.05). On average, the percent mineralization for 
Control goats was 41±1.92%, for Scaffold goats was 43±1.84%, and for BMP-2 goats 
was 45±1.88. On average, the percent mineralization was 40±2.20% at 3 months, 
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44±2.20% at 6 months, 44±2.14% at 9 months and 45±2.14% at twelve months (Fig 3-5). 
While no significant difference was apparent over time, the average percent 
mineralization over time appeared to follow a bone remodeling curve in that 
mineralization initially increased (new bone was laid down), decreased as the ostectomy 
gap remodeled and then proceeded to increase again. This was regardless of group.   
Histomorphometry assessment of Goldner’s Trichrome staining found that the 
percent osteoid formation was significantly different between groups and across time 
points; however, there was no group by time point interaction (P<0.05). On average, 
Scaffold goats and BMP-2 goats had greater percent osteoid formation (6.96±0.46% and 
6.97±0.46%) as compared to Control goats (3.67±0.48%). On average, the osteoid 
percentage of area in the ostectomy gap decreased over time, with a slight increase at 9 
months then final decrease at 12 months regardless of group [(3-6.79±0.55%a, (6)-
5.67±0.55ab, (9)-6.36±0.53%a, (12)-4.63±0.54b ; Fig 3-6]. This significant difference over 
time supports an active ostectomy remodeling gap regardless of group that mimics the 
percent mineralization in an equal and opposite direction in that new bone (osteoid) is 
initially laid down, mineralized, and then remodeled and decreases over time.   
Osteoclast count per mm of bone surface found a significant difference between 
group, time point, and a group by time point interaction existed (P<.05). The average 
osteoclast count decreased over time for Scaffold goats and BMP-2 goats, while the 
average osteoclast count remained static for Control goats (Fig 3-7, Table 3-4). 
Assesment of fluorescent microscopy (percent bone formation) revealed that there 
was no significant difference between group, time point, and group by time point 
interaction (P>0.05). Oxytetracycline is an antibiotic that complexes with metal ions such 
as calcium and becomes incorporated into bone enabling it to be used as a marker of bone 
formation. It can be detected for months post-injection as bone turn-over can take years. 
This may explain why there was no difference over time. Goats in the study were double 
labeled (once prior to surgery and again prior to euthanasia) in the hopes of being able to 
detect a bone formation rate. Due to healing of most of the gaps by 3 months, this 
detection was no longer possible. The average percent bone formation for Control goats 




The use of a long-term bone-healing model to evaluate scaffolds that resembles 
closely the normal fracture healing process is of great interest for bone regeneration. 
Long-term bone regeneration studies are lacking, especially for the study of synthetic 
biomimetic materials [6]. A cost effective large animal preclinical model is of the utmost 
importance for meeting FDA and ISO 10993 standards are critical [6]. An efficacious 
model may speed development of medical devices for bone tissue engineering reducing 
the rates of non-unions, need for amputation, or costly secondary revision surgeries.  
A significant outcome for this study was that 80% of the goats survived to their 
expected time point. The most significant short-term complication was osteomyelitis 
within one-month post-operatively. The second most common complication was 
associated with orthopedic complications related to the locking plate itself (9%). The 
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most common complication was bending of the locking plate, or screw pull out. These 
complications have been noted previously in large animal segmental defect models [19]. 
In contrast to an earlier ovine study that noted a lower stiffness of a limited contact 
locking compression plate as compared to a dynamic compression plate, our study was 
able to successfully use a custom made 8-hole locking plate for up to 12 months [19]. 
One significant difference is that our custom- made 8-hole plate did not have screw holes 
in the middle of the plate which was centered on the gap created by the segmental defect. 
Anchorage into the main fragments proximal and distal to the ostectomy gap are 
important and our plate design allowed for screws to be placed farther from the 
ostectomy gap in a buttress fashion [42, 43]. This in combination with the application of 
the use of padded splint bandage for 60 days may account for fewer orthopedic 
complications seen in this study. Additionally, as we aimed to study bone healing and 
osseointegration of the implant, our control defects were allowed to heal and therefore a 
non-union was not ensured [19].  
Serial imaging was performed with radiographs and dual energy x-ray 
absorptiometry (DEXA). While conventional radiographs have long been the standard for 
assessment of fracture healing, they have limited use for evaluation of biomaterials and 
fracture healing[44]. The use of DEXA has long been a means of assessing osteoportic 
bone and used in animal models [45, 46]. We successfully used DEXA as a means of 
studying osseointegration. While, radiographically, it appeared that scaffold goats had 
lower healing scores, by use of DEXA, there was greater bone mineral density within the 
ostectomy gap, which may be attributable to the presence of the decellularized bone 
particles in the scaffold and guided bone formation with less pronounced woven bone 
during the regenerative phase.  Computed tomography bone density appeared to follow a 
standard bone-remodeling curve, regardless of treatment group, showing an initial 
increase in bone density after 3 months with a minor drop after 6 months and increase 
again to 12 months. Computed tomography has been shown to be a parameter for 
macroscopic assessment of osseo-integration, and BMP-2 goats appeared to have greater 
osseo-integration as compared to Scaffold goats [47].  
 One salient observation was the percentage of group two (scaffold) goats that 
made it to a bridging callus and biomechanical testing. Of the twenty-six goats in group 
two, nineteen were able to form a sufficient bridging callus regardless of time point. 
While not statistically different with regard to load-to-failure, more BMP-2 goats were 
able to form a bridging callus as opposed to group two goats. Once a bridging callus was 
formed, the load-to-failure was equivocal among groups. It previously has been 
recognized that polyurethanes used in orthopedic biomaterials have been chosen for some 
of their mechanical and degradation properties [48, 49]. This synthetic polymer has been 
previously combined with nanohydroxyapatite allowing the biomaterial to bind to living 
bone tissue providing osteo-conductivity and biocompatibility [48, 49]. To these author’s 
knowledge, few studies have studied this polymer biomaterial combination in a large 
animal model beyond a relatively short time period, or against a bone healing model, to 
further investigate its potential osseo-integrative properties [50].  
 Of chief importance was this study’s ability to provide long-term follow up with a 
negative control group that served as a bone-healing model for comparison. On 
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microscopic evaluation, group one (control) goats showed a mean percent area of 
mineralization that increased in a manner that would be expected for bone formation [51]. 
Bone healing should progress from soft callus formation, to hard callus formation, and 
then proceed to bone remodeling [51]. During the remodeling process, irregular woven 
bone is converted to lamellar bone and the original cortical structure is returned [51]. The 
greatest disadvantage of this model was the stress shielding that occurred due to the 
locking plate placed in a buttress fashion. This stress shielding resulted in the cis cortex, 
or that closest to the plate often becoming thinned [6, 19]. As expected, there was an 
initial increase in mineralization, followed by a decrease as bone was remodeled, coupled 
with a second period of increase as bone was returned to its original structure [51]. In line 
with this concept, percent osteoid formation was opposite to that of mineralization such 
that there was initially a large amount of immature bone that was initially great and then 
fell accordingly as bone, or the fracture, remodeled and healed. Scaffold goats and BMP-
2 goats had greater percent osteoid formation as compared to Control goats [52]. Finally, 
it appeared as though there was little osteoclastic activity associated with group one goats 
once the bridging callus was formed with the average osteoclast count being less than one 
per mm of bone surface. This may be due to the observation that most group one goats 
had formed a bridging callus based on radiographic scores by sixty days, and remodeling 
was based on stress biomechanics rather than true bone remodeling [6, 42].  This would 
leave osteoclastic activity limited to degredation of the biomaterial thus explaining why 
there was an increased osteoclast count in the group two and group three goats that 
decreased to that of the group one goats over time. 
 Overall results demonstrate that scaffold + rhBMP-2 treatment resulted in more 
goats reaching a bridging callus that was able to withstand load-to-failure testing. 
Treatment with rhBMP-2 also resulted in scaffolds that were better integrated based on 
macroscopic assessment. Based on microscopic assessment, rhBMP2 treatment resulted 
in goats that were equivocal to the bone healing model control at 12 months in terms of 
percent area mineralization and osteoclastic resorption. These results highlight the ability 
of our scaffold to deliver growth factors. While rhBMP2 continues to be a growth factor 
of controversy, as of this moment, for large bone defects, there are few alternatives [53-
57]. Of note, bone formation was not present in muscle or any other ectopic locations as 
all goats underwent full post-mortem examination. This highlights the capability of the 
scaffold to serve as an eluting device for growth factors though further kinetic studies are 
necessary to define the optimal dose and elution rates. 
Future studies to improve this model would be to remove the locking plate once 
the bridging callus is present. One disadvantage of this model was the stress shielding 
that occurred due to the locking plate placed in a buttress fashion. This stress shielding 
resulted in the cis-cortex, or that closest to the plate often becoming thinned [6, 42]. 
Earlier removal of the plate may overcome the limitation of the thinning of the cis cortex 
and may improve radiographic scoring over time. Previous studies have shown that some 
iterations of this scaffold have the ability to deliver mesenchymal stem cells [57]. We 
now have the basis to show that our material scaffold elutes growth factors, and with the 
addition of growth factors shows superior osseo-integragraion compared to the material 
alone. Speculatively, in areas of potential non-union the addition of mesenchymal stem 
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cells could enhance the bone tissue regeneration using our material as a delivery 
platform. Finally, after the first sixty days, goats were free to return to group housing and 
required minimal maintenance beyond housing requirements. This allowed for a long-
term efficacious model that may bridge the need to provide a large animal preclinical 
model that is both cost effective and repeatable [6].  
 
Conclusions 
Overall the results presented here demonstrate the effectiveness of a multi-
layered-nanohydroxyapatite-polyurethane-decellularized bone particle based scaffold in 
the treatment of long bone segmental defects which is enhanced when used as a delivery 
device for rhBMP2. The results of this study have shown a successful, repeatable large 
animal preclinical model of segmental defect long bone healing that provides a bone-
healing model for comparison of osseo-integration of synthetic based materials. 
Evaluation of our multi-layered material showed superior integration at 3, 6, 9, and 12 
months with the addition of rhBMP2 as compared to the material alone. Strengths of this 
study include validation of the importance of a non-treatment control and the long-term 
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Figure 3-1. Multi-layered nHA-PU-DBP based scaffolds implanted into 2.5 cm 
segmental defects in the goat tibia.   
A) Representation of the PU-nHA film and adding decellularized bone particles in a 
layer-by-layer method. B) A custom made 8-hole locking plate was placed in a buttress 
fashion and 2.5 cm full thickness segment of the tibia was removed with an osteotomy 
saw. C) In scaffold or scaffold+BMP2 treatment groups, the scaffold was trimmed to the 
appropriate length such that it fit snugly into the proximal and distal segments. D) The 
remaining screws were placed and tightened.    
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Table 3-1. Radiographic scoring for assessment of ostectomy gap filling.  









































Ostectomy Gap Filling Score 
No interval change compared to immediate post-
operative radiographs 
0 
New bone filling <25% of ostectomy gap 1 
New bone filling 26-50% of ostectomy gap 2 
New bone filling 51-75% of ostectomy gap 3 
New bone filling >75% of ostectomy gap but not 
completely healed 
4 
Ostectomy gap completely filled and/or bridging 






Table 3-2. Final group break down showing the number of defects in each group 
that healed (formed a bridging callus) versus those showing insufficient healing 




























































































































Figure 3-2. Radiographs were acquired monthly.  
This figure represents radiographs from significant time points in bone healing and group 
progression. Radiographic scores increased over time for all groups (P<0.05). Group one 
(control; 5.47±0.24) and group three (scaffold+ E.Coli rhBMP-2; 5.17±0.24) goats had 
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Figure 3-3. DEXA Imaging and Analysis. 
A) A goat positioned in sternal recumbency allowing for DEXA imaging. Imaging was 
easily repeated at monthly intervals. B) Bone mineral density (BMD) increased in all 




















































































































Scaffold+BMP-2 1.461 0.130a 
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Figure 3-4. Computed tomography (CT). 
Performed after humane euthanasia at each time end point once the locking plate had been removed. 3D reconstructed anterior 
posterior and medial to lateral projections are provided at each time end point. A region of interest was drawn over the scaffold 
material (with or without BMP-2) and density was calculated in Hounsfield units. On average the density of the scaffold was 
less in group BMP-2 goats (612.17HU ±50.44) as compared to Scaffold goats (854.61HU ± 47.45) proving better osseo-
integration of the material with the addition of BMP-2. 
Group 3 Months 6 Months 9 Months 12 Months 
3D  AP Medial AP Medial AP Medial AP Medial 
Scaffold 
        
Scaffold
+BMP-2 




Figure 3-5. Von Kossa (percent mineralization) staining.  
A) There was no significant difference in the percent mineralization between groups. B) Although there was no significant 
difference in percent mineralization over time, the amount of mineralization appears to follow a bone remodeling curve in that 
it initially increases as the ostectomy gap is filled with new bone that is then remodeled. C) Von Kossa stained samples where 
black represents mineralized bone. In Scaffold and BMP-2 goats, the scaffold took staining indicating the presence of 





Figure 3-6. Goldner’s Trichrome (percent osteoid) staining.  
There was a significant difference in the percent mineralization between groups (P<0.05) in that on average Scaffold and BMP-
2 goats had greater percent osteoid formation (6.96±0.46% and 6.97±0.46%) as compared to Control goats (3.67±0.48%) B) 
There was a significant difference in osteoid staining over time, in that the osteoid percentage of area in the ostectomy gap 
decreased over time, with a slight increase at 9 months then final decrease at 12 months regardless of group [(3-6.79±0.55%a, 
(6)-5.67±0.55ab, (9)-6.36±0.53%a, (12)-4.63±0.54b]. C) Goldner’s Trichrome stained samples where green represents 






             
Figure 3-7. The average osteoclast count per mm of bone surface. 
There was a group by month interaction in that the average osteoclast count decreased 
over time for Scaffold and BMP-2 goats, while the average osteoclast count remained 



















































































Scaffold+ BMP-2 0.417±0.799b 
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CHAPTER 4.  
CHARACTERIZATION OF POST-OPERATIVE HYPERTROPHIC 















































This study used phenotypic tests and whole genome sequencing to characterize a 
collection of Staphylococcus aureus isolates from goats with clinical evidence of 
osteomyelitis following tibial ostectomy. S. aureus positive goats with clinical evidence 
of osteomyelitis were evaluated based on radiographic and histomorphometric analysis 
for phenotypic evidence of proliferative bone production. Isolates were identified using 
biochemical analysis combined with MLST of S. aureus in whole genome sequence-
based contigs. All isolates were noted to be ST 398 and S. aureus infected goats were 
noted to have proliferative bone reaction. Further investigation into potential unique 





































Staphylococcus aureus is a gram positive bacteria that is the most common 
pathogen in bone infection, or osteomyelitis [1-3]. Osteomyelitis itself may be the result 
of hematogenous spread of bacteria such as seen in the pediatric population [4, 5]. It may 
be the result of a contiguous focus inoculation such as seen secondary to a fracture or 
surgical site infection, or osteomyelitis associated with vascular insufficiency such as that 
seen with diabetic ulcers [4, 5]. The mechanisms by which S. aureus successfully invades 
and thrives in the bone environment are complex and not fully understood [4]. It is now 
recognized that S. aureus is no longer strictly an extracellular pathogen [6, 7]. S. aureus, 
in vitro, has been shown to have the ability to invade osteoblasts and survive in an altered 
metabolic state [8, 9]. Infected osteoblasts may be subject to altered osteoblast 
physiology [10, 11]. Currently, very little is known about how the S. aureus-osteoblast 
relationship may result in bone formation.  
The gold standard of the study of long bone healing has been through the use of 
ostectomy gap models [12, 13]. One of the most popular models is the tibial ostectomy 
gap model in goats [13]. One complication of this model is infection, either of the 
surgical site or the implant itself [12, 13]. Regardless of the site of infection, the resulting 
osteomyelitis is classified as contiguous focus. With S. aureus being inoculated into 
healthy bone it may cause bone infection either through genes that encode microbial 
surface components recognizing adhesive matrix molecules (MMSCRAMMs) that allow 
it to attach to osteoblasts or through invading osteoblasts and surviving in an altered 
metabolic state [14]. Radiographs have shown that osteomyelitis cases show proliferative 
periosteal reaction and exuberant new bone formation in the initial stages of osteomyelitis 
[15]. Histomorphometric assessment allows for the quantification of osteoid (or the 
amount of forming bone), mineralization (mature bone), and osteoblastic activity (via 
tetracycline labelling) [16]. The ostectomy gap model provides the benefit of phenotypic 
in-vivo assessment of potential altered osteoblast proliferation in that bone formation may 
be quantified and assessed by both radiographic and histomorphometric analysis.  
Whole genomic sequencing of S. aureus isolates causing clinical osteomyelitis 
may provide insight as to whether the phenotypic affects are the result of unique factors 
present within the population of clinical isolation. It is known that some strains of S. 
aureus are more virulent than others [17]. There is little knowledge about strain 
dependent differences in the ability of S. aureus to alter osteoblastic activity towards 
bone production. One way to differentiate strains is the use of multi-locus sequence 
typing (MLST [18]. MLST weas first developed in the late 90’s to identify internal 
nucleotide sequences of approximately 400 to 500 bp in typically seven housekeeping 
genes [18, 19]. For S. aureus these genes are typically acrC, aroE, glp, gmpm, pta, tpi 
and yqiL, respectively coding for specific proteins [20]. The different sequences are 
assigned as distinct alleles and defined by the alleles at each of the seven housekeeping 
loci [19]. There are many alleles at each of the seven loci making it highly unlikely to 
have identical allelic profiles by chance [19]. It is considered the “gold standard” of 
typing bacteria. MLST allele sequences and ST profile tables are becoming more 
accessible with updated databases and software [18].  
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While MLST has typically been used to classify strains of S. aureus in community 
acquired cases of methicillin resistant staphylococcus aureus, it can also be used to 
classifty isolates in an understandable and comparable global context [18]. Work has yet 
to be done that defines MLST of strains S. aureus as they relate to potential proliferative 
bone formation cases of osteomyelitis. The aims of this study was to investigate whether 
clinical cases of osteomyelitis from goats with a tibial ostectomy gap showed phenotypic 
evidence of proliferative osteoblastic bone production and if the S. aureus isolated from 
these cases were unique in terms of multilocus sequence typing.  
 
Materials and Methods 
Case Population 
All experimental procedures and protocols were approved by the animal care and 
use committee (University of Tennessee IACUC 2383). From a larger study of 105 goats 
(Chapter III) that had undergone a 2.5 cm tibial ostectomy that was repaired with a 
4.0mm locking plate, a total of thirteen goats developed clinical evidence of osteomyelitis 
(dehiscence and/or infection of the surgical site with initial proliferative bone formation) 
and were pre-emptively available for inclusion. Of these thirteen, eleven cultured S. 
aureus based on biochemical identification.  
Radiographs were performed immediately post-operatively and then monthly until 
end points (NEXT Equine DR, Sound, Carlsbad, CA., USA). Radiographs were scored 
by a board certified radiologist to assess ostectomy gap filling and the presence of 
hypermineralization (excessive periosteal reaction; Table 4-1).4  
Upon diagnosis of osteomyelitis, goats were subjected to humane euthanasia. 
Tibia segments were trimmed and placed in 95% ethanol. Using an automated tissue 
processor (ASP300S, Leica, Germany) tissues were dehydrated in a series of ethanol 
solutions of increasing concentration (70%, 80%, 95% x2, 100% x3) over a period of 
several days at ambient temperature and a programmed auto-cycle of pressure, vacuum, 
and gentle agitation. Specimens were next transferred to three separate exchanges of 
100% Methyl Salicylate (Sigma-Aldrich, St. Louis, MO) over the course of 48-72 hours, 
manually cycled between gentle agitation (modified stir bar setup) and vacuum at -15-20 
in Hg (Fisherbrand, Vacuum Chamber), and observed for complete dehydration. 
Specimens were transferred to 100% xylenes (Sigma-Aldrich, Histological Grade, St. 
Louis, MO) for a quick rinse before being placed back onto the automated tissue 
processor (ASP300S, Leica, Germany) for three changes of 100% xylenes to complete 
the tissue clearing and prepared for methyl methacrylate resin infiltration. Specimens 
were then manually managed through three separate and fresh in-house prepared 
Infiltration Solution (IS I, IS II, IS III) exchanges of methyl methacrylate (Sigma-
Aldrich, St. Louis, MO) and dibutyl phthalate (Sigma-Aldrich, St. Louis, MO), under 
ambient temperature over the course of 1.5 - 2 weeks, and with a manually cycled switch 




4 All figures and tables for this chapter are presented in the appendix. 
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between gentle agitation (modified stir bar setup) and vacuum @ -15-20 in Hg 
(Fisherbrand, Vacuum Chamber).  
After a satisfied period of resin infiltration, specimens were transferred to 
prelabelled polypropylene containers and pre-polymerized base molds, where a fourth 
and in-house prepared final resin solution was then added along with a benzoyl peroxide 
based catalyst (Perkadox-16, AKZO Nobel Chemicals, Chicago, IL) to initiate a 
polymerization reaction to cure each specimen into a bubble free, clear, hardened, methyl 
methacrylate (MMA) block over a period of approximately 5-8 days. Each specimen 
block was then trimmed using a wet bandsaw (MarMed Bone Wet Band Saw) so that 
resulting microtomed sections would fit onto pre-cleaned 50mm x 75mm glass 
microscope slides (Fisherbrand). Specimen blocks were shaped for microtomy and 
sections cut at five microns using a motorized SM2500 sledge microtome (Leica, 
Germany) and d-profile (sledge) tungsten-carbide knives (Delaware Diamond Knives). 
Each section cut was mounted to an individual 50mm x 75mm precleaned glass 
microscope slide (Fisherbrand) that was coated with an in-house gelatin based solution 
recipe (Haupt’s Solution) and covered with a plastic protective strip. Prior to staining, 
slide-sections from each specimen were sorted for fluorescence microscopy, VonKossa 
staining or Goldner’s Trichrome staining. Prior to staining, all sections were deplasticized 
in a similar fashion that traditional paraffin sections would be deparaffinized so that all 
tissue components can be uninhibited during staining molecule interactions. 
To quantitatively assess the percentage of mineralization (VonKossa), osteoid 
formation (Goldner's Trichrome), gross images from each slide were grossly acquired 
and digitized using a Panasonic HC-V770 (picture size 8M, 3264x2448, aspect ratio 4:3, 
extra optical zoom 20x) and processed in ImageJ (Rasband, W.S., Image J, U.S. National 
Institutes of Health, Bethesda Maryland, USA, https://imagej.nih.gov/ij/, 1997-2018.). 
For percentage mineralization, images were made binary such that mineralized bone was 
the parameter quantitatively assessed. For osteoid formation, images were made binary 
such that osteoid was the quantitatively assessed parameter. Unstained sections were 
evaluated by fluorescence microscopy with an excitation filter and two stop filters 
allowing radiation with a wavelength between 490 and 520 nm that permitted the 
identification and morphometric analysis of the mineralizing surface of bone.  
Bacterial Isolates and Culture Methods 
All experimental procedures and protocols were approved by the animal care and 
use committee (University of Tennessee IACUC 2383). From October 2017 to December 
2018 a total of 12 nonduplicate bacterial isolates were collected from tibial ostectomy 
sites from 10 goats in a project unrelated to this study. All strains were collected 
aseptically, transferred into Amies gel without charcoal (BBL CultureSwab Plus 220116, 
USA) and directly plated.  
Isolation and Phenotypic Identification of Staphylococcus aureus 
Each isolated bacterial sample from Amies media was initial evaluated on 
Columbia blood (5% sheep blood) agar (Reme, R01217, USA) and CNA 
(colistin/naladixic acid with 5% sheep blood) agar (Remel, R01322, USA), incubated at 
35 degrees Celcius in 5% CO2. Additionally samples were evaluated on MacConkey II 
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(Remel, R01552, USA) and thioglycollate broth (Remel, R453452, USA), incubated at 
35 degrees Celsius in ambient room temperature for 24 hours. 
Tube coagulase (rabbit plasma), phenol red broth with trehalose, phenol red broth 
with lactose, and Vogues Proskaur (VP) broth were performed on all beta-hemolytic 
gram positive cocci.  All biochemical were incubated at 35 degrees Celsius in ambient 
room temperature and read at 14 hours with the exception of VP which was read at 48 
hours. For S. aureus, all biochemical had a positive reaction. Susceptibility testing was 
performed on 18-24 hours isolates via disc diffusion (Remel discs, USA). 
Genomic analysis  
Of the 11 goats that cultured S. aureus, one was unavailable for whole genome 
sequencing. In two goats, two unique strains of S. aureus were cultured and each strain 
was sequenced separately. This left a total of 12 strains of S. aureus available for whole 
genomic analysis from 10 goats with clinical evidence of osteomyelitis.  
A single bacterial colony of each strain, grown on blood agar plates, was 
inoculated into 5 mL of sterile Trypticase soy broth (TSB) and incubated overnight at 37 
C with shaking at 225 rpm using an Excella E24 incubator shaker (New Brunswick 
Scientific, USA). DNA was extracted using the MasterPure DNA purification kit 
(Epicentre, USA) according to the manufacturer’s instructions. 
Sequencing libraries were constructed using the Nextera DNA sample prep kit 
(Illumina, Inc., USA) according to the manufacturer’s instructions for all strains. Initially 
four sequences were sequenced using a MiSeq platform (Illumina, Inc) with a single-end 
read length of 150 bp at the University of Tennessee Genomics Core facility, the results 
of which were published (Abouelkhair, 2018). Following this, the remaining sequences 
were sequenced using a HiSeq platform with paired-end read length of 150 bp at 
Novogene (Sacramento, CA, USA). All sequences were trimmed with Trimmomatic 
v.039, assembled using SPAdes (v3.14.0) and annotated using the Kbase version of 
Prokka (v1.12). For MLST the data base at the University of Oxford 
(https://pubmlst.org/saureus) for whole-genome multilocus sequence typing was used.  
Statistical analysis 
The case matching population was not large enough to make statistical 
comparisons therefore results are limited to descriptive terms only and reported as means 
± standard deviation (STD). Raw descriptive data of each strain of osteomyelitis is 
provided in Table 4-2.   
Results 
Radiographic Analysis 
One goat was removed from analysis due to an incomplete data set (lack of whole 
genomic sequencing data). This left 10 goats available for radiographic analysis. In 
regards to ostectomy gap filling, eight of the ten (80%) S. aureus goats had an ostectomy 
gap healing score of less than 2 (or new bone filling of less than 25% of the ostectomy 
gap). Only two out of ten (20%) showed a healing score of greater than 2. If the influence 
of the biomaterial was removed, and only goats with a negative control gap were 
evaluated, five out of seven (71%) of goats showed healing scores of less than 2, while 
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two out of 7 (29%) showed healing scores greater than 2. When compared back to the 
general population of goats as a whole, if the influence of the biomaterial was removed, 
S. aureus goats were able to show comparable scores to their uninfected counterparts 
(Chapter III). Based on descriptive radiographic analysis, S. aureus goats showed prolific, 
irregular, and palisading periosteal reactions (Fig 4-1).  
Histomorphometric Analysis 
A total of 5 goats had complete data sets available for histomorphometic analysis 
with case matched controls. For Goldner’s Trichrome staining, or percent osteoid 
formation, S. aureus goats showed a percent osteoid formation of 12.94% ± 2.35. In 
terms of percent mineralization, or VonKossa staining, S. aureus goats showed 
mineralization of 49.46% ± 16.37. Finally, when evaluating the percent fluorescence or 
the amount of osteoblastic activity, S. aureus goats showed osteoblastic activity of 2.52% 
± 3.18. When compared to back to the greater population, this appears to be an increase 
in osteoid formation, mineralization, and osteoblastic activity (Fig 4-2).  
Genomic Analysis 
The number of contigs, G=C content values, and the total lengths of the draft 
genome sequences for the clinical isolates of S. aureus are listed in Table 4-3. For HiSeq 
reads, a subset of the whole genomic sequence was taken such that there was 40x 
coverage of the genome. Additionally the number of predicted coding sequences as 
estimated by KBase are provided. All isolates were identified as sequence type (ST) 398 
based on multi-locus sequence typing.  
 
Discussion 
We discovered that goats, from an unrelated orthopedic study, infected with S. 
aureus ST 398 were prone to develop a substantial amount of bone formation associated 
with osteomyelitis. It was observed that ST 398 is putatively capable of causing bone 
formation. Up until this point, it has been thought that proliferative amount of bone has 
been due to contiguous-focus osteomyelitis due to the fact that the resulting cases of 
spontaneous osteomyelitis occurred after surgery (direct trauma). Contiguous focus 
osteomyelitis may provide a key insight into how S. aureus able to infect healthy bone 
[21]. The exact mechanism that resulted in the exuberant bone formation after SA 
infection with this ST remains to be determined.  
One way to further investigate the potential impact of these clinical isolates is 
further bioinformatics analysis. S. aureus clinical strains could be compared back to 
known S. aureus inducting strains of osteomyelitis and non-osteomyelitis inducing 
strains. This would allow functional annotation comparisons and comparisons between 
virulence databases. Assemblies could be subjected to whole genome alignment to detect 
any difference between the clinical isolates [22]. Alternatively, functional annotation and 
virulence databases could be compared on a variety of platforms [23-27]. One phenotypic 
assessment that maybe due to virulence factors or unknown proteins maybe made in that 
proliferative bone formation, or hypermineralization was associated with surgical site 
infection. If no surgical site infection was present, the bone tended follow the more 
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typical appearance of osteolytic or bone loss associated with osteomyelitis if cases those 
cases were allow to progress beyond one month of observation [1].   
Previous studies have investigated bone formation as a radiographic parameter of 
osteomyelitis [15]. There results proved that bone formation is a constant and early 
feature of osteomyelitis, and has the strongest association to microbiological results [15]. 
However, these studies have not attempted to classify whether the amount of bone 
formation is sequence-dependent [15]. While not statistically significant, if the effect of 
the biomaterial was removed the S. aureus goats showed equivocal healing to case 
matched controls. The effect of the biomaterial in the presence of infection is not known. 
Currently work is being done with the biomaterial as both an antibiotic eluting device and 
bone regeneration scaffold which may have altered the results of ostectomy gap healing 
[20]. The bone formation seen radiographically was confirmed with histomorphometry. 
Tetracycline labelling binds reforming bone [16]. While not significant, the amount of 
remodeling bone was greater in S. aureus goats as compared to controls. Further wok 
investigating whether this is a direct cause and an effect is needed. It is not known 
whether the proliferative bone reaction as the result of the immune system attempt to deal 
with the suspected internalized S. aureus or whether this was a direct effect of the S. 
aureus- osteoblast relationship.  
Major evolutionary changes in the ST 398 lineage have occurred over time [29]. 
The first being a widening infection spectra of these bacteria to humans livening in 
animal-free environments, and second an increase in its intrinsic virulence capacity [30, 
31]. One important study has shown that methicillin sensitive S. aureus ST 398 is easily 
transmissible among humans [30]. Additionally, its genome is well adapted to the human 
host [30]. Unfortunately, this study only compared ST 398 strains found in humans to 
livestock associated methicillin resistant strains of S. aureus ST 398 [30]. There remains 
a gap in knowledge as to how S. aureus ST 398 relates to known contiguous-focus 
inducing OM strains of SA, and whether increased bone formation is the result of unique 
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Ostectomy Gap Filling Score 
No interval change compared to immediate post-
operative radiographs 
0 
New bone filling <25% of ostectomy gap 1 
New bone filling 26-50% of ostectomy gap 2 
New bone filling 51-75% of ostectomy gap 3 
New bone filling >75% of ostectomy gap but not 
completely healed 
4 
Ostectomy gap completely filled and/or bridging 





Table 4-2. Descriptive data of each strain of osteomyelitis subjected to whole 
genomic sequencing.  





















Strain MLST Biomaterial Surgical Site 
Infection 
Hypermineralization 
MI 18-33 398 Yes Yes Yes 
MI 18-34 398 No Yes Yes 
MI 18-935 
 
398 No Yes Yes 
MI 18-1974 398 No Yes Yes 
MI 18-4421 398 Yes No No 
MI 18-3926a 398 Yes No No 
MI 18-3225 398 No No No 
MI 18-2814a 398 No Yes Yes 
MI 18-2814b 398 No Yes Yes 
MI 18-3857 398 Yes No No 
MI 18-2759 398 No Yes Yes 
MI 18-3926b 398 Yes No No 
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Figure 4-1. Radiographic ostectomy gap filling of an S. aureus goat and a case 
comparsion.  
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Figure 4-2. Tetracycline labelling of an S. aureus goat and a case comparsion.  
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CHAPTER 5.  














































The above work comprised in these chapters represents research conducted to 
evaluate the long-term effect of a three dimensional synthetic bone regeneration scaffold, 
with and without the addition of BMP-2. The scaffold was implanted into a large 
segmental bone defect to assess the inherent and enhanced capability to promote bone 
formation. Additionally, when complications of osteomyelitis arose, clinical cases were 
compared to their case matched controls and bacteria subjected to biochemical 
identification and whole genomic sequencing.  
 Few large animal preclinical models extend beyond a ninety day time period, 
have the capacity to look at bone regeneration, and are translatable to humans [1-4]. 
Challenges associated with long-term preclinical large animal models include the ability 
to assess animal comfort, an animal’s tolerance to captivity, availability of the animal, 
society’s acceptance of the animal model, and the animal’s tolerance to captivity and the 
ease of housing [5-7]. Goats are often chosen for orthopedic research due to their ability 
to meet all of these needs [8-11].   
 Currently subjective visual assessment of gait is the standard of care in practice to 
assess lameness, and there appears to be no validated standards for objective gait analysis 
in goats [12-19]. The results of chapter II allowed for an objective baseline to be made. 
Quantitative gait assessment of biometric forces during ambulation in goats free of 
lameness using a pressure-sensing mat allowed for objective measurements of the 
animal’s comfort during the long-term study.  
 While a wide variety of synthetic materials have been researched in effort to 
improve healing of debilitating fractures, no synthetic material has yet to be better than 
the gold standard autograft [20]. A 3D biomaterial from our lab has undergone extensive 
in-vitro and small animal in-vivo assessments. A tibial segmental defect model in the 
goat was chosen for the large animal preclinical model as discussed in chapter III. The 
results of the study demonstrated the effectiveness of the material when combined with 
the growth factor BMP-2. Additionally, the “negative” control gap turned into a positive 
control as controls goats showed ostectomy gap healing. This provided a bone-healing 
model for cmparison of osseo-integration of the synthetic based material.  
 Finally, bone infection is a complication of any orthopedic procedure [21, 22]. In 
our population of S. aureus goats, all strains were identified as sequence type 398 based 
on multilocus sequence typing after whole genomic sequencing. The phenotypic change 
of proliferative bone was found prompting potential for further investigation as to how S. 
aureus ST 398 may result in increased bone formation associated with osteomyelitis.  
 
Future Research 
The need for large animal preclinical models and evaluation of their most 
common complication, osteomyelitis, is complex. To expand the large animal preclinical 
model, work needs to be done for rehabilitation not only of the bone but of the whole 
limb in order to assess full return of function. The preclinical model presented here 
provides the advantage of potentially being able to remove the locking plate once the 
bone has healed to further assess osseo-integration.  
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 Finally, the proliferative amount of bone associated with early osteomyelitis has 
been of particular interest to me. It remains to be seen whether this is associated with 
strain specific differences of S.aureus, and if it is truly an effect of S. aureus on 
osteoblast physiology. The results of such work may identify preventive and therapeutic 





















































































1. Pearce, A. I., Richards, R. G., Milz, S., Schneider, E., & Pearce, S. G. (2007). 
Animal models for implant biomaterial research in bone: a review. Eur Cell 
Mater, 13(1), 1-10. 
2. McGonigle, P., & Ruggeri, B. (2014). Animal models of human disease: 
challenges in enabling translation. Biochemical pharmacology, 87(1), 162-171. 
3. Van der Worp, H. B., Howells, D. W., Sena, E. S., Porritt, M. J., Rewell, S., 
O'Collins, V., & Macleod, M. R. (2010). Can animal models of disease reliably 
inform human studies?. PLoS medicine, 7(3), e1000245. 
4. Hackam, D. G., & Redelmeier, D. A. (2006). Translation of research evidence 
from animals to humans. Jama, 296(14), 1727-1732 
5. Flower FC, Sanderson DJ, Weary DM. Hoof pathologies influence kinematic 
measures of dairy cow gait. J Dairy Sci. 2005;88(9):3166-3173. doi: 
10.3168/jds.S0022-0302(05)73000-9. 
6. Flower FC, Weary DM. Gait assessment in dairy cattle. Animal. 2009;3(1):87-95.  
7. Black LL, Gaynor J, Gahring D, Adams C, Aron D, Harman S, et al. Effect of 
adipose-derived mesenchymal stem and regenerative cells on lameness in dogs 
with chronic osteoarthritis of the coxofemoral joints: a randomized, double-
blinded, multicenter controlled trial. Vet Ther. 2007;8(4):272-284. 
8. Harvey EJ, Giannoudis PV, Martineau PA, Lansdowne JL, Dimitriou R, Moriarty 
TF, et al. Preclinical animal models in trauma research. J Orthop Trauma. 
2011;25(8):488-493. doi: 10.1097/BOT.0b013e3182251421. 
9. Reichert JC, Saifzadeh S, Wullschleger ME, Epari DR, Schütz MA, Duda GN, et 
al. The challenge of establishing preclinical models for segmental bone defect 
research. Biomaterials. 2009;30(12):2149-2163. doi: 
10.1016/j.biomaterials.2008.12.050. 
10. Pearce AI, Richards RG, Milz S, Schneider E, Pearce SG. Animal models for 
implant biomaterial research in bone: a review. Eur Cell Mater. 2007;13(1):1-10. 
11. Fulton LK, Clarke MS, Farris Jr HE. The goat as a model for biomedical research 
and teaching. Ilar J. 1994;1;36(2):21-29. 
12. Muri K, Stubsjøen SM, Valle PS. Development and testing of an on-farm welfare 
assessment protocol for dairy goats. Anim Welfare. 2013;22(3):385-400. 
13. Browning Jr R, Leite-Browning ML, Byars Jr M. Reproductive and health traits 
among Boer, Kiko, and Spanish meat goat does under humid, subtropical pasture 
conditions of the southeastern United States. J Anim Sci. 2011;89(3):648-660. 
doi: 10.2527/jas.2010-2930. 
14. Deeming LE, Beausoleil NJ, Stafford KJ, Webster JR, Zobel G. The development 
of a reliable 5-point gait scoring system for use in dairy goats. J Dairy Sci. 
2018;101(5):4491-4497. doi: 10.3168/jds.2017-13950. 
15. Gigliuto C, De Gregori M, Malafoglia V, Raffaeli W, Compagnone C, Visai L, et 
al. Pain assessment in animal models: do we need further studies?. J Pain Res. 
2014;7:227-236. doi: 10.2147/JPR.S59161. 
110 
  
16. Hill NP, Murphy PE, Nelson AJ, Mouttotou N, Green LE, Morgan KL. Lameness 
and foot lesions in adult British dairy goats. Vet Rec. 1997;141(16):412-416. 
17. Olechnowicz J, Jaśkowski JM. Lameness in small ruminants. Med Weter. 
2011;67(11):715-719. 
18. Vieira A, Oliveira MD, Nunes T, Stilwell G. Making the case for developing 
alternative lameness scoring systems for dairy goats. Appl Anim Behav Sci. 
2015;171:94-100. 
19. Anzuino K, Bell NJ, Bazeley KJ, Nicol CJ. Assessment of welfare on 24 
commercial UK dairy goat farms based on direct observations. Vet Rec. 
2010;167(20):774-780. doi: 10.1136/vr.c5892. 
20. Fillingham, Y., & Jacobs, J. (2016). Bone grafts and their substitutes. The bone & 
joint journal, 98(1_Supple_A), 6-9. 
21. Muthukrishnan, G., Masters, E. A., Daiss, J. L., & Schwarz, E. M. (2019). 
Mechanisms of Immune Evasion and Bone Tissue Colonization That Make 
Staphylococcus aureus the Primary Pathogen in Osteomyelitis. Current 
osteoporosis reports, 17(6), 395-404. 
22. Waldvogel, F. A., Medoff, G., & Swartz, M. N. (1970). Osteomyelitis: a review 
of clinical features, therapeutic considerations and unusual aspects. New England 






 Rebecca Elaine Rifkin, born in February 1988, received her doctorate in 
veterinary medicine in May of 2013. She then completed a rotating internship at Pioneer 
Equine Hospital followed by a second internship at California Equine Orthopedics. She 
was in private practice as a racetrack veterinary at Zimmer Equine Sports Medicine prior 
to coming to the University of Tennessee, Knoxville. She was accepted into the 
comparative and experimental graduate program in 2016 and began to pursue her PhD 
under the mentorship of David Anderson. Her studies focused on in-vivo assessments of 
a large animal preclinical model associated with a biomaterial in an ostectomy gap 
model. She has written and submitted her dissertation for review for a planned graduation 
for the spring of 2020.  
 During her time in graduate school, Rebecca has published a manuscript as a first 
author. This publication constitutes chapter II in this work. In addition to publication, she 
has presented a collection of poster and oral presentations at symposia and conferences 
hosted by the CEM department at UTK, and the American College of Veterinary 
Surgeons (ACVS).  
 
